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Abstract 
FUNCTIONAL CHARACTERIZATION OF ATXA,  
THE BACILLUS ANTHRACIS VIRULENCE REGULATOR 
Publication No.________ 
Troy G. Hammerstrom, B.S. 
Supervisory Professor: Theresa M. Koehler, Ph.D. 
Coordinated expression of virulence genes in Bacillus anthracis occurs via a multi-
faceted signal transduction pathway that is dependent upon the AtxA protein.  Intricate 
control of atxA gene transcription and AtxA protein function have become apparent from 
studies of AtxA-induced synthesis of the anthrax toxin proteins and the poly-D-glutamic acid 
capsule, two factors with important roles in B. anthracis pathogenesis.  The amino-terminal 
region of the AtxA protein contains winged-helix (WH) and helix-turn-helix (HTH) motifs, 
structural features associated with DNA-binding. Using filter binding assays, I determined 
that AtxA interacted non-specifically at a low nanomolar affinity with a target promoter (Plef) 
and AtxA-independent promoters.  AtxA also contains motifs associated with 
phosphoenolpyruvate: sugar phosphotransferase system (PTS) regulation. These PTS-
regulated domains, PRD1 and PRD2, are within the central amino acid sequence.  Specific 
histidines in the PRDs serve as sites of phosphorylation (H199 and H379).  Phosphorylation 
of H199 increases AtxA activity; whereas, H379 phosphorylation decreases AtxA function. 
For my dissertation, I hypothesized that AtxA binds target promoters to activate transcription 
and that DNA-binding activity is regulated via structural changes within the PRDs and a 
carboxy-terminal EIIB-like motif that are induced by phosphorylation and ligand binding. I 
determined that AtxA has one large protease-inaccessible domain containing the PRDs and 
the carboxy-terminal end of the protein. These results suggest that AtxA has a domain that is 
distinct from the putative DNA-binding region of the protein. 
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 My data indicate that AtxA activity is associated with AtxA multimerization. Oligomeric 
AtxA was detected when co-affinity purification, non-denaturing gel electrophoresis, and 
bis(maleimido)hexane (BMH) cross-linking techniques were employed.  I exploited the 
specificity of BMH for cysteine residues to show that AtxA was cross-linked at C402, 
implicating the carboxy-terminal EIIB-like region in protein-protein interactions.  In addition, 
higher amounts of the cross-linked dimeric form of AtxA were observed when cells were 
cultured in conditions that promote toxin gene expression.  Based on the results, I propose 
that AtxA multimerization requires the EIIB-like motif and multimerization of AtxA positively 
impacts function. 
I investigated the role of the PTS in the function of AtxA and the impact of 
phosphomimetic residues on AtxA multimerization.  B. anthracis Enzyme I (EI) and HPr did 
not facilitate phosphorylation of AtxA in vitro.  Moreover, markerless deletion of ptsHI in B. 
anthracis did not perturb AtxA function. Taken together, these results suggest that proteins 
other than the PTS phosphorylate AtxA.  Point mutations mimicking phosphohistidine (HD) 
and non-phosphorylated histidine (HA) were tested for an impact on AtxA activity and 
multimerization.  AtxA H199D, AtxA H199A, and AtxA H379A displayed multimerization 
phenotypes similar to that of the native protein, whereas AtxA H379D was not susceptible to 
BMH cross-linking or co-affinity purification with AtxA-His.  These data suggest that 
phosphorylation of H379 may decrease AtxA activity by preventing AtxA multimerization.   
Overall, my data support the following model of AtxA function.  AtxA binds to target 
gene promoters in an oligomeric state. AtxA activity is increased in response to the host-
related signal bicarbonate/CO2 because this signal enhances AtxA multimerization.  In 
contrast, AtxA activity is decreased by phosphorylation at H379 because multimerization is 
inhibited. Future studies will address the interplay between bicarbonate/CO2 signaling and 
phosphorylation on AtxA function. 
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Chapter I:  Introduction 
Introduction 
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1.1 Gene regulation in response to environmental signals  
The ability to respond to niche-specific stimuli is key to thriving in changing 
environments and a defining characteristic of life.  Organisms within all domains of life have 
various methods to react to niche-specific signals, and a common response is to control 
gene expression.  Cis- and trans-acting factors can promote or impede transcription of genes 
encoding proteins that produce a proper response.  In bacteria, the process of signal 
transduction occurs most often via classical two-component systems (TCS) containing a 
histidine kinase and a response regulator (reviewed in (1).  Histidine kinases contain motifs 
which sense a change in the environment and then transmit the signal to the kinase domain 
to induce autophosphorylation.  The phosphorylated kinase domain promotes 
phosphorylation of the response regulator which then interacts with promoter elements of 
specific genes.   There are several variations on the theme of TCS. Some systems have 
multiple inputs. Some use more than two proteins to shuttle phosphate from the sensing 
protein to the regulator.  Sometimes a single protein senses a signal and alters gene 
expression.  The numerous mechanisms used to respond to the environment indicate that 
understanding the proteins involved in signal transduction is crucial to understanding life. 
 B. anthracis, the etiological agent of anthrax disease, has two distinct lifestyles that 
require drastically different gene expression profiles.  As a pathogen in mammalian tissue 
and as a saprophyte associated with rhizospheres, signal transduction is crucial for the 
bacterium to adapt and thrive in each niche. The work I present in this dissertation focuses 
on the protein AtxA, which is the linchpin in the transition from a soil-dwelling bacterium to a 
mammalian pathogen. 
 
1.2 Bacillus anthracis and Anthrax Disease 
B. anthracis is a non-motile, Gram-positive bacterium and contains a 5.23 Mb 
chromosome and two large plasmids, pXO1 (182 kb) and pXO2 (96 kb) (2–4).  The plasmids 
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harbor genes necessary for virulence.  The structural genes for the anthrax toxins, pagA 
(Protective Antigen, PA), cya (Edema Factor, EF), and lef (Lethal Factor, LF), are located 
noncontiguously on pXO1 (Fig. 1-1, (5–7).  The capsule biosynthetic operon (capBCADE) is 
located on pXO2 (8). 
For many years, it was thought that the plasmids were unique to B. anthracis; 
however, several strains within the Bacillus cereus group have been isolated with pXO1- or 
pXO2-like plasmids (9, 10).  In addition to B. anthracis, the B. cereus group includes Bacillus 
thuringiensis, an insect pathogen, and B. cereus, an opportunistic pathogen which can also 
cause food poisoning.  All three of these species normally reside in the soil.   
Replication in soil is an under-studied area of the B. anthracis infection cycle.  Saile 
and Koehler (11) were the first to show germination of spores in the rhizosphere.  Cells were 
metabolically active as demonstrated by the transfer of genetic material from one strain of B. 
anthracis to another.  More recently, two studies provided evidence that B. anthracis may 
reside within earthworm intestines and that bacteriophages play a significant role in 
genotypic and phenotypic alteration (12, 13).   
 The first step in the infection process occurs when spores from the environment enter 
the host.  The spores are engulfed primarily by macrophages, although other cell types have 
been implicated in this process as well (14, 15).  Spores are transported to regional lymph 
nodes where they germinate and produce several different virulence factors.  After release, 
B. anthracis spreads rapidly until the victim perishes due to bacteremia (16).  Upon death of 
the host, the bacilli develop into dormant spores and re-enter the local ecosystem. B. 
anthracis spores are highly resistant for long periods, greater than 200 years (17), to 
environmental insults such as heat, desiccation, and UV light. 
The route spores of B. anthracis enter the host dictates the symptoms and outcomes 
of the infected mammal or human.  Cutaneous anthrax manifests when spores invade the 
host through a cut or wound in the skin.  A large wound called a black eschar develops at the   
  4 
site of infection (18, 19).  Gastro-intestinal anthrax occurs when diseased meat or 
contaminated food products are eaten.  The disease is marked with fever, bloody diarrhea, 
vomiting, and abdominal pain (20).  B. anthracis is most lethal when spores are inhaled into 
the lungs.   The victim develops flu-like symptoms which lead to a misdiagnosis of the 
disease (16, 20).  Infections will result in mortality unless the recommended antibiotics, 
ciprofloxacin and doxycyline, are administered early during the infection (20, 21).  It is 
notable to mention that anthrax disease has not been found to be transmitted from one 
person to another. 
  
1.3 Virulence Determinants of B. anthracis  
 Of the many proteins needed by B. anthracis to cause anthrax disease, the two major 
virulence factors are the anthrax toxin and poly-γ-D glutamic acid (PDGA) capsule.  The 
anthrax toxin proteins are the most abundant proteins secreted from the cell.  Toxemia 
induced via injection of the toxins into an animal or delayed antibiotic treatment of an 
infection will result in death of the host (22–24).  The importance of the PDGA capsule has 
also been demonstrated.  A murine model for anthrax disease succumbs to infection of 
capsulated, nontoxinogenic strains with a similar dose of spores and survival time as 
capsulated, toxinogenic strains (25). 
   The anthrax toxin is an atypical A-B type toxin which contains a single binding (B) 
moiety, protective antigen (PA, 83 kDa), and two enzymatic (A) proteins, edema factor (EF, 
89 kDa) and lethal factor (LF, 90 kDa).    After PA binds to the anthrax toxin receptor on host 
cell membranes, a furin-like protease cleaves PA to release a 20-kDa fragment (PA20) (26, 
27).  The remaining 63-kDa PA polypeptide (PA63) spontaneously forms a seven-member 
pre-pore structure on the cell membrane (28).  The pre-pore, which is capable of binding up 
to three molecules of EF and/or LF (29), is endocytosed and transported to early endosomes 
(30).  Upon acidification of the vesicle, PA forms a pore (31) and facilitates EF and LF 
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translocation into the cytoplasm of the host cell (32).  EF functions as a calmodulin-
dependent adenylate cyclase to increase cAMP levels in the afflicted cell (33). Elevated 
levels of cAMP, a potent second messaging molecule, cause changes in neutrophil function 
and disruptions in the cellular water balance (34). LF is a Zn-dependent metalloprotease 
which targets and cleaves mitogen-activated protein kinase kinases (35, 36).  Degradation of 
the LF targets results in suppression of proinflammatory cytokines (37) and may induce 
apoptosis (38).  
As a means of evading immune detection, B. anthracis constructs a PDGA capsule. 
The capsule is a polymer of amino acid residues while other bacterial capsules are 
polysaccharides.  The PDGA capsule is found only in B. anthracis and a few recently 
discovered B. cereus and B. thuringiensis strains (9, 10).  The humoral response of the 
immune system only detects the capsule weakly.  This allows the bacteria to proliferate 
without raising much alarm.   
 Lesser known virulence factors also play roles in B. anthracis pathogenesis.  
Phospholipases function to cleave the phospholipid head groups from the non-polar tails 
resulting in destabilization of the plasma membrane and lysis of the cell.  Three 
phospholipases are present in B. anthracis, and each has specificity for a different class of 
phospholipids (39).  InhA1, a well-studied metalloprotease, has been shown to cleave host 
proteins as well as B. anthracis-derived products (24, 40–43). Alo, a cholesterol-dependent 
cytolysin, forms pores in host cell membranes leading to the entrance of Ca2+ into the host 
cytoplasm (44).  Strains with gene deletions of these factors have slightly less virulence than 
a parent strain during the course of infection.  Nevertheless, each protein is thought to act in 
a critical niche or step in pathogenesis (39, 45).     
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Figure 1-1.  Model of virulence gene activation in B. anthracis. Transcriptional and post-
translational control of AtxA allows B. anthracis to coordinate expression of the toxin genes 
(cya, lef, and pagA) and the poly-D-glutamic acid (PDGA) capsule biosynthetic operon 
(capBCADE).  The atxA gene (colored blue) is affected positively via temperature and 
carbohydrate availability and negatively via growth phase cues and redox conditions.  
Metabolic activity and phosphorylation of the AtxA PRDs result in stabilization and changes 
in the protein’s activity, respectively.  The most important signal in the cascade is 
CO2/bicarbonate which affects AtxA protein function.  Several factors involved in the signal 
transduction remain unknown (indicated by the winding black arrows).  The known players in 
each pathway are in parentheses.  AtxA activates transcription (green arrows) of the toxin 
genes, acpA, cap operon, and other genes located on pXO1, pXO2, and the chromosome 
(not depicted).  AcpA and AcpB (colored red) are AtxA-like regulators of the cap operon.  
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1.4 The Anthrax toxin Activator, AtxA 
The Anthrax toxin Activator AtxA is required for activation of the virulence genes in B. 
anthracis (Fig. 1-1, (46–48).  Deletion of atxA, which is located on pXO1, leads to attenuation 
of virulence in murine models for anthrax disease presumably due to decreased transcription 
of the anthrax toxin genes and the capsule biosynthetic operon (46, 47, 49–54).  Transcript 
levels of at least 47 genes on the virulence plasmids and the chromosome are changed in a 
ΔatxA strain (55–57).  AtxA-dependent promoters do not display any consensus sequence.  
However, all three toxin genes contain structural similarity (58).   
The phenotypes of an atxA-null strain indicate that atxA is important for virulence and 
that the function of the protein should be discerned.  Based on the sequence of the 475 
amino acids within AtxA, it is predicted that AtxA contains five motifs (Fig. 1-2) (59, 60).  The 
56-kDa, soluble basic protein has two DNA-binding motifs at the amino terminus in the form 
of winged-helix (WH) and helix-turn-helix (HTH) motifs (51, 59, 60).  Two 
phosphoenolpyruvate: carbohydrate phosphotransferase system (PTS) regulation domains 
(PRDs) are encoded after the DNA-binding region.  The last 90 amino acids are similar to an 
Enzyme IIB (EIIB) motif of the PTS (60).     
AtxA function is affected by phosphorylation of the PRDs while a metabolic state 
regulator impacts AtxA protein amount.  The PRDs within AtxA are phosphorylated at H199 
and H379 (59).  Using HA and HD mutations in AtxA to mimic the non-phosphorylated 
and phosphorylated states, respectively, Tsvetanova et al. suggest that a phosphohistidine at 
position 199 increases AtxA activity while H379 phosphorylation decreases protein function.  
The activity of AtxA is decreased when AtxA is phosphorylated at both residues.  CodY is a 
pleiotropic regulator which represses genes during early exponential phase of growth when 
metabolic activity is high (61).  In a ΔcodY strain, AtxA protein amount is decreased severely.  
Transcription and translation rates are unaffected in this mutant; therefore CodY regulates 
AtxA indirectly via a post-translational mechanism (62). 
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Figure 1-2.  Comparison of AtxA and PRD-containing proteins. AtxA contains five 
putative motifs: a winged helix-turn-helix (WH), a helix-turn-helix (HTH), two PTS regulation 
domains (PRDs), and an Enzyme IIB-like (EIIB-like) motif.  PRD-containing proteins are 
shown as a comparison to AtxA.  Mga contains a conserved Mga domain (CMD-1) and two 
HTH motifs upstream of the PRDs and EIIB-like motif.  MtlR and LicR are similar to AtxA and 
Mga; however, MtlR and LicR encode an Enzyme IIA-like (EIIA-like) motif.  Another variation 
is seen in LevR.  It has the same domains as MtlR and LicR, except there is an NtrC Central 
Domain and the PRDs are separated by the EIIA-like and EIIB-like motifs.  LicT and GlcT are 
antiterminators; they contain RNA-binding motifs and two PRDs.  Several other PRD-
containing proteins have been discovered (not depicted). Phosphorylated histidines are 
labeled for each protein.  Phosphorylation sites that lead to increased function of the protein 
are colored green, whereas the red residues indicate sites which decrease the protein’s 
activity.  
  9 
Environmental signals and trans-acting factors, other than CodY, affect atxA 
transcription predominantly at the P1 promoter 99 nucleotides upstream of atxA (49).  A 
second weaker promoter (P2) is located approximately 750 nucleotides in front of the 
translational start site (63).  The environmental signals impacting atxA are temperature, 
redox state, and carbohydrate availability (64–66).  Increased transcription of atxA occurs at 
37° C versus 28° C and in the presence of glucose and not glycerol.  In agreement, carbon 
catabolite activation (CCA) is present, since mutation of the ccpA, encoding the catabolite 
control protein A, leads to a decrease in atxA transcription (66).  Cytochrome c is involved in 
sensing the redox state of the cell.  An increased amount of atxA is detected when 
cytochrome c-deficient B. anthracis mutants are cultured in non-toxin inducing conditions 
(65).  AbrB, a transition state regulatory protein, binds upstream of the P1 transcriptional start 
site of atxA and down-regulates atxA during exponential phase of batch culture growth (67, 
68).   
Several signals affect virulence of B. anthracis; however, CO2/bicarbonate appears to 
be the most critical host-associated factor needed for AtxA-dependent virulence gene 
expression (Fig. 1-1).  Virulence genes are transcribed optimally when B. anthracis is 
cultured in a buffered medium in the presence of bicarbonate and 5% or greater CO2 (47, 49, 
50, 69–71).  Previous work demonstrated that the CO2/bicarbonate-dependent induction of 
the toxin genes was abrogated in an atxA-null mutant (47). This pointed to atxA as the 
mediator for the CO2/bicarbonate signal, but the small molecule does not affect transcription 
rate of atxA or stability of the AtxA protein (25, 47, 54, 72).   
 
1.5 Regulation of PRD-containing proteins and CcpA via the Phosphoenolpyruvate: 
carbohydrate phosphotransferase system 
 The role of the PRDs, CcpA, and CodY in AtxA expression and function indicates that 
the metabolic state of B. anthracis affects virulence gene regulation.  The 
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phosphoenolpyruvate: carbohydrate phosphotransferase system (PTS) is the major 
carbohydrate import and utilization machine within bacteria (Fig. 1-3, (73).  CcpA activity and 
regulation of PRDs is controlled by the PTS. 
The primary task of the PTS is to recycle phosphate from the end of glycolysis to 
carbohydrates as they enter the cell. The PTS is composed of two general enzymes, 
Enzyme I (EI) and HPr, and sugar-specific Enzyme II (EII) complexes.  PTS-dependent 
carbohydrates are recognized and transported via one of four EII superfamilies: the glucose-
fructose-lactose superfamily, the ascorbate-galactitol superfamily, the mannose family, and 
the dihydroxyacetone family.  EII complexes consist of A, B, C, and in some cases D 
motifs/proteins and may be one protein with multiple domains (EIIABC) or divided into up to 
four proteins containing each motif separately or in tandem (i.e. EIIA and EIICB) (73).   
The phosphotransfer begins as EI catalyzes the conversion of phosphoenolpyruvate 
(PEP) to pyruvate resulting in EI phosphorylated at a conserved histidine. EI~P transfers the 
chemical group to HPr at H15 (Bacillus subtilis numbering), which subsequently 
phosphorylates EIIA. EIIA~P phosphorylates EIIB which transfers its phosphate to 
carbohydrate molecules crossing the cell membrane via the EIIC(D) complex.  The 
phosphorylated sugar serves as a substrate in glycolysis or other catabolic pathways (73). 
It is significant to note that the PTS also functions to regulate gene expression based 
on available sugars.  HPr is the main player in carbon catabolite repression (CCR) and 
carbon catabolite activation (CCA) in low-G+C Gram-positive bacteria, such as B. anthracis 
(Fig. 1-3).  In addition to EI-dependent phosphorylation of HPr at H15 (P~His-HPr), the HPr 
kinase/phosphorylase (HprK/P) phosphorylates HPr at S46 (P-Ser-HPr).  EI activity is 
affected by the PEP/pyruvate ratio; whereas, HprK/P modifies HPr in an ATP-dependent 
manner in response to high levels of fructose-1,6-bisphosphate.  Two methods of HPr-
dependent signaling relevant to this work include activation of the catabolite control protein 
(CcpA) and phosphorylation of PTS regulation domains (PRDs) (73).   
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Figure 1-3.  HPr-dependent processes related to carbohydrate metabolism. 
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Figure 1-3.  HPr-dependent processes related to carbohydrate metabolism. HPr is 
phosphorylated by Enzyme I (EI) or HprK/P.  EI converts PEP to pyruvate when PEP 
concentrations are high.  The reaction produces a phosphorylated EI.  (1) EI~P 
phosphorylates HPr at His15.  (2) EIIA is one target of P~His-HPr.  P~EIIA phosphorylates 
EIIB, which in turn phosphorylates the sugar (S) transported via EIIC/D.  (3) PRD-containing 
proteins are phosphorylated by P~His-HPr to induce activity whereas EIIA- or EIIB-
dependent phosphorylation decreases activity.  PRD-containing proteins function as 
transcriptional antiterminators or activators.   P~His-HPr has other targets not depicted.  (4) 
Ser46 of HPr is phosphorylated by HprK/P when high levels of ATP and fructose-bis-1,6-
phosphate (FBP) are present.  P-Ser-HPr forms a heterotetramer with CcpA, and (5) the 
complex binds to promoters to induce carbon catabolite activation (CCA) or repression 
(CCR).  Blue arrows represent a transfer of phosphate.  Black arrows indicate other 
processes.  
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CcpA, a B. subtilis DNA binding protein within the LacI/GalR family of transcriptional 
regulators, induces CCA and CCR after interacting with P-Ser-HPr or an HPr-like protein 
called Crh (reviewed in (74).  Similar to HPr, Crh can be phosphorylated at S46.   
Heterotetramers of CcpA/P-Ser-HPr or CcpA/P-Ser-Crh bind to catabolite response elements 
(cre) located in promoter regions.  If a cre is upstream of a transcriptional start site, CcpA/P-
Ser-HPr will activate the promoter upon binding.  Conversely, when the cre is downstream of 
the transcriptional start, CcpA/P-Ser-HPr acts as a repressor to decrease transcription of the 
gene. The CcpA/P-Ser-HPr regulon includes ~10% of the B. subtilis genome, and in several 
pathogenic bacteria, CcpA plays a role in virulence (75).  Deletion of ccpA in B. anthracis 
causes a decrease in the transcription of atxA (66).  Transcription of mga, the regulator of 
early virulence traits in group A Streptococcus (GAS), is affected by ccpA (76).   
PRD-containing proteins typically function as transcriptional activators or 
antiterminators.  The B. subtilis protein LicT is the prototypical PRD-containing protein.  It 
contains an amino-terminal RNA-binding motif followed by two PRDs (Fig. 1-2).  LicT 
antiterminates transcription of genes needed to import and metabolize β-glucosides (77).  
The effect of the PTS on PRD-containing proteins is varied for each regulator and can be 
different based on the sites phosphorylated via P~His-HPr and a specific class of EIIA and/or 
EIIB (Fig. 1-3).  In LicT, HPr phosphorylates H207 and H269 within PRD2 and H100 in PRD1 
is phosphorylated by BglP, the β-glucosides-specific EIIBCA complex (78). Structural studies 
have shown that the HPr-dependent phosphorylation of PRD2 promotes dimer formation 
causing an increase LicT activity (79).  In contrast, phosphorylation of PRD1 decreases 
activity by destabilizing the dimeric form (80).  Based on the study of LicT and other PRD-
containing antiterminators, PRDs have three main properties: (i) PRDs contain 5 α-helices, 
(ii) histidine residues within the PRDs are phosphorylated via proteins in the PTS, and (iii) 
phosphorylation of the PRDs leads to structural changes affecting the activation state of the 
protein.  
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Other PRD-containing proteins function as transcriptional activators.  LicR and MtlR 
contain DNA-binding motifs at the amino-terminus, followed by two PRDs, an EIIB-like motif 
and an EIIA-like motif (Fig 1-2, ((81, 82)). Slight variations on the motif organization also exist 
since LevR contains an NtrC central domain and has its PRDs separated by EIIA-like and 
EIIB-like motifs (83).  Like LicT, the PRDs within these proteins are phosphorylated; 
however, EIIB-like and EIIA-like motifs can be phosphorylated as well (73).  Modification of 
MtlR, a regulator of mannitol utilization found in B. subtilis and Geobacillus 
stearothermophilus, is the best understood of the PRD-containing transcriptional activators 
(82, 84, 85).  PRD2 of MtlR contains two histidines that are phosphorylated by HPr.  The Mtl-
specific EIIA (EIIAMtl) phosphorylates MtlR at a conserved cysteine in the EIIB-like motif, and 
the EIIBMtl domain (within the EIICBMtl protein) is responsible for phosphorylating H599 in the 
EIIA-like motif of MtlR (82).  Phosphorylation of PRD2 induces DNA binding by MtlR while 
phosphorylation of the EIIB-like or EIIA-like motif is antagonistic (84). 
 
1.6 AtxA homologues in Gram positive low G+C pathogens 
Recently, PRDs were discovered in several virulence gene regulators:  Mga in GAS; 
AtxA, AcpA, and AcpB in B. anthracis; and the Mga-like protein and EbpR in Enterococcus 
faecalis (59, 86–88).  These proteins contain amino-terminal DNA-binding motifs, internal 
PRDs, and a carboxy-terminal EIIB-like motif and regulate virulence-associated genes (Fig. 
1-2, (86).  This small family of proteins could have functional and structural similarity.     
The most-studied of the PRD-containing virulence regulators is Mga (86).  Originally 
described as the regulator of the emm gene, Mga controls approximately 10% of the GAS 
genome during exponential phase of growth (89).  In vitro electrophoretic mobility shift 
assays (EMSAs) show Mga binding specifically to several GAS promoters (90).  Mga has 
three amino-terminal features that affect DNA binding and gene activation.  One major HTH 
(HTH-4, residues 107-126) and one minor HTH (HTH-3, residues 53-72) are thought to 
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interact with DNA specifically (91).  In addition, a small motif called the conserved Mga 
domain-1 (CMD-1) is required for Mga-dependent activation of promoters (92).  Recently, 
Mga has been shown to contain an EIIB-like motif and to be phosphorylated via HPr and EI 
(McIver, personal communication).  Phosphorylation of H204 and H270 decreases Mga 
activity, whereas phosphorylation of H324 increases the function of the protein.   
The Anthrax capsule Activator (AcpA) and AcpB, a homologue of AcpA, are encoded 
on pXO2 of B. anthracis and are part of the AtxA/Mga family.  The proteins have high 
similarity to each other (62%) and to AtxA (AcpA-AtxA, 50%; AcpB-AtxA, 50%; Drysdale, 
2004).  The capsule biosynthesis operon is regulated at the transcriptional level via AtxA, 
AcpA, and AcpB (Fig. 1-1, (93, 94)).  In a laboratory-derived, genetically-complete strain of B. 
anthracis, atxA and either acpA or acpB are necessary for PDGA capsule synthesis.  Single 
deletions of acpA or acpB resulted in an insignificant decrease in capsule production. AcpA 
and AcpB may appear to be functionally redundant; however, a ΔacpB strain is slightly 
attenuated compared to the parent and ΔacpA strains (25).  AtxA increases expression of 
acpA twenty-fold at one of its two promoters, and the other promoter is activated at a low 
constitutive level.  In addition to an atxA-independent promoter directly upstream of acpB, its 
transcript level is thought to be enhanced by read-through transcription from the cap operon 
(95).   
The only structural information about an AtxA/Mga family member was obtained when 
researchers at the Argonne National Laboratory solved the X-ray crystal structure of an Mga-
like protein from E. faecalis (PDB entry 3SQN,(88)).  No functional or genetic data is 
available for this protein, except that it crystallized as a dimer.  The structure shows the EIIB-
like motif from one monomer is encircled by the DNA-binding motif and PRDs of the other 
monomer (Fig 1-4).  Interestingly, another AtxA/Mga-like protein, EbpR, is present in E. 
faecalis and regulates pilus biogenesis and biofilm formation (87).  Similar to AtxA, EbpR 
function is increased in buffered medium containing bicarbonate and CO2 (96).  
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Figure 1-4.  Crystal structure of the Mga-like protein of E. faecalis.  The cartoon 
structure of the Mga-like protein homodimer (3sqn PDB file) is shown.  Subunit A is colored 
blue.  The DNA-binding elements and PRDs of Subunit B are red and the EIIB-like motif is 
green.  Three representations of the structure are shown with different rotations around the 
y- or x-axis.        
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1.7 Gaps in knowledge and significance of this work 
 Studies of AtxA protein function in B. anthracis will reveal the mechanism used to 
control virulence gene expression in response to environmental signaling. Moreover, the 
knowledge of the specific system used by B. anthracis will increase our overall 
understanding of signal transduction and microbial pathogenesis.  
 B. anthracis is a model bacterial pathogen.  Few bacteria require both intracellular 
and extracellular mechanisms of immune evasion and survival.  The organism utilizes toxins 
and a capsule like other pathogens, yet the virulence traits within B. anthracis have several 
unique features.  The genome contains a chromosome and two large virulence plasmids 
which encode for the virulence factors.  Regulators on all three genetic elements can 
influence gene expression on the other DNA molecules.  The processes of spore formation 
and germination allow for studies related to the development and morphogenesis of 
organisms.  Finally, powerful biochemical and genetic tools, many developed in the related 
species B. subtilis, are available when working with B. anthracis.   
Activation of B. anthracis virulence requires AtxA; however, it is not understood how 
AtxA functions to regulate virulence genes.  For my thesis work, I hypothesize that AtxA 
binds target promoters to activate transcription when structural changes within the PRDs and 
EIIB-like motif are induced by phosphorylation and/or ligand binding.  WH and HTH motifs 
indicate DNA-binding activity though specific binding of DNA has not been shown (51, 60).  
Tsvetanova et al. (59) demonstrated that AtxA is phosphorylated and suggested the PTS is 
involved in phosphorylation.  The effect of phosphorylation and the proteins responsible have 
not been identified. AtxA function is strongly induced in the presence of CO2/bicarbonate, but 
the molecular mechanism for the impact of this signal on protein function has not been 
discerned.  
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Chapter II:  Materials and Methods 
Materials and Methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTE:  A portion of this chapter is derived from work that has been published in 2011: “The 
Bacillus anthracis virulence regulator AtxA: oligomeric state, function, and CO2-signaling.” 
Molecular Microbiology 82(3): 634-47 PMID:21923765. I am the primary author on this 
paper.  I performed all experiments described in this chapter.  I have received permission by 
the publisher of Molecular Microbiology, John Wiley and Sons, to reproduce all of the 
manuscript in print or electronically for the purposes of my dissertation (License Number: 
2796030226674) 
  19 
2.1 Culture conditions 
“B. anthracis strains were cultured at 37° C in Luria-Bertani (LB) medium (97), 
Brain Heart Infusion (BHI) medium(98) or Casamino Acid (CA) medium (99). LB broth 
cultures were shaken in air.  CA broth cultures were shaken in air or in 5% 
atmospheric CO2. For CA cultures incubated in elevated CO2, 0.8% sodium 
bicarbonate was added to the medium (CACO3) (100). Cells from stationary phase 
cultures were transferred into fresh medium (CACO3, unless noted otherwise) to an 
initial optical density at 600nm (OD600) of approximately 0.08.  Cultures were 
incubated for 7 h and the OD600 was determined hourly. Generally, cultures reached 
early-exponential phase (OD600 0.20 to 0.35) at 2 h and stationary phase (OD600 1.2 
to 1.7) at 4 h. For strains harboring atxA controlled by the hyper-spank promoter 
(Phs) (101), expression was induced with 30-50 µM isopropyl β-D-thiogalactoside 
(IPTG) at 2 h and cells were harvested at 4 h. 
“Antibiotics were used when appropriate in the following concentrations: 
spectinomycin (50 µg ml-1 for E. coli and 100 µg ml-1 for B. anthracis), erythromycin 
(150 µg ml-1 for E. coli and 5 µg ml-1 for B. anthracis), and carbenicillin (100 µg ml-1 for 
E. coli). Antibiotics and other chemicals were purchased from Fisher Scientific 
(Fairlawn, NJ) or Sigma-Aldrich (St. Louis, MO) unless indicated otherwise.” (102) 
 
2.2 Strain Construction 
 “B. anthracis strains and plasmids are shown in Table 2-1. All B. anthracis 
mutants were derived from the parent strain ANR-1 (Ames non-reverting), a pXO1+ 
pXO2- isolate originally obtained from Ames (pXO1+ pXO2+) (103). E. coli strains 
JM109, TG1, and GM2163 were employed as hosts for cloning plasmids. 
Amplification, manipulation, and isolation of plasmid DNA were performed according 
to general practices. Non-methylated plasmid DNA was obtained from E. coli  
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Table 2.1 B. anthracis strains and plasmids 
Name Description Reference 
Strains   
ANR-1 Parent strain, pXO1+, pXO2- (103) 
UT375 lef promoter–lacZ fusion (Plef-lacZ) at native lef locus This work 
UT376 lef promoter–lacZ fusion (Plef-lacZ) at native lef locus, 
atxA-null 
This work 
UT405 ANR-1, ptsHI-null This work 
UT408 lef promoter–lacZ fusion (Plef-lacZ) at native lef locus, 
ptsHI-null 
This work 
   
Plasmids   
pHT304-18z Low-copy vector harboring a promoter-less lacZ; Erm
R
 (104) 
pUTE657 Expression vector derived from pDR111 and pBC16 
with IPTG-inducible Phyper-spank; Spec
R
Amp
R
 
(105) 
pUTE658 pUTE657 - derived expression vector for AtxA; the 
atxA ribosome binding site and coding region 
controlled by Phyper-spank 
This work 
pUTE843 pHT304-18z - derived reporter vector for atxA; -72 to 
+99 of the atxA promoter (relative to the P1 
transcriptional start) is upstream of lacZ 
(106) 
pUTE991 pUTE658 - derived expression vector for AtxA-His 
(hexa-histidine tag on the C-terminus of AtxA) 
This work 
pUTE992 pUTE658 - derived expression vector for AtxA-FLAG 
(FLAG tag on the C-terminus of AtxA) 
This work 
pUTE1013 pUTE657 - derived expression vector for GFP-FLAG 
(FLAG tag on the C-terminus of GFP); the gfpmut3a 
ribosome binding site, coding region, and sequence 
encoding FLAG controlled by Phyper-spank 
This work 
pUTE1018-FLAG pUTE657 - derived expression vector for AtxA1-164-
FLAG (FLAG tag on the C-terminus); the atxA 
ribosome binding site, coding region, and sequence 
encoding FLAG controlled by Phyper-spank 
This work 
pUTE1019-FLAG pUTE657 - derived expression vector for AtxA1-385-
FLAG (FLAG tag on the C-terminus); the atxA 
ribosome binding site, coding region, and sequence 
encoding FLAG controlled by Phyper-spank 
This work 
pUTE1020-GFP-
FLAG 
pUTE657 - derived expression vector for AtxA167-385-
GFP-FLAG (GFP-FLAG tag on the C-terminus); the 
atxA ribosome binding site, coding region, and 
sequence encoding GFP-FLAG controlled by Phyper-
spank 
This work 
pUTE1021-GFP-
FLAG 
pUTE657 - derived expression vector for AtxA167-475-
GFP-FLAG (GFP-FLAG tag on the C-terminus); the 
atxA ribosome binding site, coding region, and 
sequence encoding GFP-FLAG controlled by Phyper-
spank 
This work 
 
  21 
Table 2.1 B. anthracis strains and plasmids (continued) 
Name Description Reference 
pUTE1022-
FLAG 
pUTE657 - derived expression vector for AtxA385-475-
FLAG (FLAG tag on the C-terminus); the atxA 
ribosome binding site, coding region, and sequence 
encoding FLAG controlled by Phyper-spank 
This work 
pUTE1022-
GFP-FLAG 
pUTE657 - derived expression vector for AtxA385-475-
GFP-FLAG (GFP-FLAG tag on the C-terminus); the 
atxA ribosome binding site, coding region, and 
sequence encoding FLAG controlled by Phyper-
spank 
This work 
pUTE1032 pUTE657 - derived expression vector for His-HPr 
(hexa-histidine tag on the N-terminus of HPr); the 
ptsH ribosome binding site, sequence encoding the 
His tag, and ptsH coding region controlled by 
Phyper-spank 
This work 
pUTE1034 pUTE657 - derived expression vector for HPr and 
EI; the ptsH ribosome binding site, ptsH coding 
region, ptsI ribosome binding site, and ptsI coding 
region controlled by Phyper-spank 
This work 
pUTE1040 pUTE657 - derived expression vector for His-EI 
(hexa-histidine tag on the N-terminus of EI); the ptsI 
ribosome binding site, sequence encoding the His 
tag, and ptsI coding region controlled by Phyper-
spank 
This work 
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GM2163 for electroporation into B. anthracis (47, 107).   
“All gene deletions were inserted using derivatives of pHY304, a temperature-
sensitive E. coli – B. anthracis shuttle vector harboring an erythromycin-resistance 
gene (108).   To construct UT375, in which the lef coding sequence on pXO1 was 
replaced by a promoterless -galactosidase gene (lacZ), the polymerase chain 
reaction (PCR) and primers TH126 and TH127 (Table 2-2) were used to amplify a 
797-bp DNA fragment corresponding to sequence from -686 to +111 relative to the lef 
transcriptional start site (lefup) (49). The PCR product was cloned into pHT304-18z 
(109) using PstI and BamHI restriction enzyme sites upstream of the plasmid-borne 
lacZ. Subsequently, a 854-bp DNA sequence corresponding to sequences +2510 to 
+3363 (lefdown) was amplified using primers TH128 and TH129 and cloned into the 
KpnI and EcoRI sites of pHT304-18z containing lefup. The lefup-lacZ-lefdown segment of 
DNA was removed via digestion with XhoI and EcoRI and cloned in pHY304. 
Integration of the plasmid was performed according to methods described previously 
(105).  Briefly, B. anthracis containing the plasmid was cultured at 41° C (the 
temperature non-permissive for pHY304 replication) in the presence of erythromycin 
to select for isolates in which the plasmid inserted into the lef locus via homologous 
recombination. Subsequently, cultures were passaged multiple times at 30° C in the 
absence of antibiotic to allow excision of the pHY304 derivative from the lef locus. 
Single colony isolates were tested using PCR and sequencing for replacement of the 
lef coding sequence with the promoterless -galactosidase gene.   
“To generate UT376, a markerless atxA-deletion mutant of UT375, DNA 
fragments corresponding to approximately 1 kb upstream of the atxA translational 
start (-1009 to +99 from the P1 transcriptional start site) and 1 kb downstream of the 
atxA stop codon (+1528 to +2517) were amplified using primers JR170-171 and  
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Table 2.2 Primers used in this dissertation 
Name Brief Description Sequence (5' to 3') 
TH126 Plef-lacZ insertion GACTCTGCAGCTCGAGTATGCAGTGAGGCTCTTATGATT 
TH127 Plef-lacZ insertion GATAGGATCCATAAAGACGGGACCACTCAAAG 
TH128 Plef-lacZ insertion CAGTGGTACCGGGACCAGCCATTATGAAGCAAC 
TH129 Plef-lacZ insertion GGAAGAATTCAAGATGAAGATCGACAAAATGGCTC 
JR170 atxA markerless deletion GGCCGCGGAGAGCCGCATTAAACT 
JR171 atxA markerless deletion GGGCATGTCTATAATTGATTCTCCTTTCCTG 
JR172 atxA markerless deletion GAGAATCAATTATAGACATGCCCTTTAAATATTTGTTTA
ATGACAC 
JR173 atxA markerless deletion GGCTCGAGCGCTTGTCTCACAATCTCATC 
TH235 ptsHI markerless deletion GAGATCTAGACTAGTAGCACTTGGTGGTAAAG 
TH244 ptsHI markerless deletion CAGCCTCGAGTTCATACGGAAGCTTTATCGCAC 
TH245 ptsHI markerless deletion CGACTCAGGTTTTTTTATTAATTACATGATAATTTATCT
CC 
TH246 ptsHI markerless deletion GGAGATAAATTATCATGTAATTAATAAAAAAACCTGAGT
CG 
TH191 atxA rbs (SalI)  GGTAGTCGACAGGAAAGGAGAATCAATTATAGACATGC 
TH192 atxA stop codon (SphI) CCTTGCATGCTTATATTATCTTTTTGATTTCATG 
TH198 atxA codon 475 + FLAG + 
stop (SphI) 
GGGCATGCTATTTATCATCATCATCTTTATAATCTATTA
TCTTTTTGATTTCATGAAAAT 
TH199 atxA codon 475 + His6 + 
stop (SphI) 
GGGCATGCTAGTGGTGGTGGTGGTGGTGTATTATCTTTT
TGATTTCATGAAAAT 
TH254 atxA rbs + codon 167 
(SalI) 
CCAAGTCGACAGGAAAGGAGAATCAATTATAGACATGTA
TTGGCCGTTTCCCTATATTAA 
TH247 atxA rbs + codon 385 
(SalI) 
CCAAGTCGACAGGAAAGGAGAATCAATTATAGACATGCT
ATTTAAAAATAACCCG 
TH257 atxA codon 164 + FLAG + 
stop codon (SphI) 
GGGCATGCTATTTATCATCATCATCTTTATAATCTGGAA
TATTGCAATATAACC 
TH260 atxA codon 385 + FLAG + 
stop codon (SphI) 
GGGCATGCTATTTATCATCATCATCTTTATAATCCATAC
GTTGAGTTTCAAAATGCATTG 
TH267 atxA codon 385 + gfp-mut3a 
start (Forward)  
CAATGCATTTTGAAACTCAACGTATGATGAGTAAAGGAG
AAGAACTTTTCAC 
TH268 atxA codon 385 + gfp-mut3a 
start (Reverse) 
GTGAAAAGTTCTTCTCCTTTACTCATCATACGTTGAGTT
TCAAAATGCATTG 
TH212 atxA codon 475 + gfp-mut3a 
start (Forward)  
GATTTTCATGAAATCAAAAAGATAATAATGAGTAAAGGA
GAAGAACTTTTCAC 
TH213 atxA codon 475 + gfp-mut3a 
start (Reverse) 
GTGAAAAGTTCTTCTCCTTTACTCATTATTATCTTTTTG
ATTTCATGAAAATC 
TH228 atxA C96S  CTAAATCTTCAAATTAGTGAAGAACTTGTATTC 
TH229 atxA C96S  GAATACAAGTTCTTCACTAATTTGAAGATTTAG 
TH216 atxA C161S  ATGTTAAGGTTATATAGTAATATTCCAAATGAT 
TH217 atxA C161S  ATCATTTGGAATATTACTATATAACCTTAACAT 
TH218 atxA C202S TCAAAACACAAATTGAGTGTGTTGTTCGCTATA 
TH219 atxA C202S TATAGCGAACAACACACTCAATTTGTGTTTTGA 
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Table 2.2 Primers used in this dissertation (continued) 
Name Brief Description Sequence (5' to 3') 
TH230 atxA C356S  AATACAATTCAAGAAAGTATTAGTAATTTAAAC 
TH231 atxA C356S  GTTTAAATTACTAATACTTTCTTGAATTGTATT 
TH222 atxA C370S  TACTCCCATTTCGACAGTTATGAAATTTCATTA 
TH223 atxA C370S  TAATGAAATTTCATAACTGTCGAAATGGGAGTA 
TH224 atxA C402S  TACACCTCACAAGGAAGTATACATCGAGAG 
TH225 atxA C402S  CTCTCGATGTATACTTCCTTGTGAGGTGTA 
TH183 atxA H199A CAAATGTACACCTATTCAAAAGCCAAATTGTGTGTG 
TH184 atxA H199A CACACACAATTTGGCTTTTGAATAGGTGTACATTTG 
TH22 atxA H199D CAAATGTACACCTATTCAAAAGACAAATTGTGTGTG 
TH23 atxA H199D CACACACAATTTGTCTTTTGAATAGGTGTACATTTG 
TH185 atxA H379A CATTATTAACAATGGCTTTTGAAACTCAACGTATGC 
TH186 atxA H379A GCATACGTTGAGTTTCAAAAGCCATTGTTAATAATG 
TH24 atxA H379D CATTATTAACAATGGATTTTGAAACTCAACGTATGC 
TH25 atxA H379D GCATACGTTGAGTTTCAAAATCCATTGTTAATAATG 
TH193 gfp-mut3a rbs (SalI) GCGCGTCGACCTCTAGATTTAAGAAGGAGATATAC 
TH234 gfp-mut3a stop codon + 
FLAG (SphI) 
GGGCATGCTATTTATCATCATCATCTTTATAATCTTTGT
ATAGTTCATCCATGCCATG 
MT10 ptsH rbs (SalI)  GGTAGTCGACATTTAAAGGAGATAAATTATCATG 
TH286 ptsH His6 + 5' end of ORF GCACACCACCACCACCACCACGAAAAAATCTTTAAAGTA
ACTAGCG 
TH287 ptsH rbs + His6  GTGGTGGTGGTGGTGGTGTGCCATGATAATTTATCTCCT
TTAAATGTC 
TH288 ptsH stop codon (SphI) ATGCATGCTTATTCTCCTAATCCTTCG 
MT12 ptsI rbs (SalI)  GGTAGTCGACAACGAAGGATTAGGAGAATAATG 
TH289 ptsI His6 + codon 2 GCACACCACCACCACCACCACACTCTTAACATTCAAGGG 
TH290 ptsI rbs + His6  GTGGTGGTGGTGGTGGTGTGCCATTATTCTCCTAATCCT
TCGTTGTC 
MT13 ptsI stop codon (SphI) GGGCATGCATCGACTCAGGTTTTTTTATTAATTA 
TH195 pUTE657 sequencing primer 
(upstream) 
GAACGTTGCTCGAGGGTAAATG 
TH196 pUTE657 sequencing primer 
(downstream) 
GGTACGTACGATCTTTCAGCC 
 
Abbreviations: rbs, ribosome binding site; His6, hexa-histidine tag; ORF, open reading frame 
Restriction enzymes are listed in parentheses.  If the primer encodes a point mutation, the 
mutagenic codon is underlined.  
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JR172-173, respectively (Table 2-2), fused via splicing by overlapping extension PCR 
(PCR-SOE) (110), and inserted into pHY304 using the SacII and XhoI restriction 
enzyme sites.  B. anthracis containing the Plef-lacZ reporter (UT375) was 
transformed with the atxA deletion construct.  The strain was cultured as described 
above and an isolate deleted for atxA was confirmed using PCR and sequencing.” 
(102)  
 The vector used to remove ptsHI from the B. anthracis chromosome contained 
sequences homologous to the regions upstream of ptsH and downstream of ptsI.  Primers 
TH235 and TH245 facilitated amplification of a 869-nt sequence upstream of the ptsH 
(GBAA_4268) start codon while TH246 and TH244 were used to amplify a 873-nt region 
downstream of the ptsI (GBAA_4267) stop codon.  The products were fused via PCR-SOE 
and cloned into pHY304 using the XbaI and XhoI restriction enzyme sites.  The plasmid 
containing the ptsHI flanking regions was electroporated into ANR-1 and UT375 to produce 
the ptsHI-null strains (UT405 and UT408, respectively) using the methods described above 
for gene deletion. 
“I cloned the atxA coding region into pUTE657 (105), which carries the IPTG-
inducible promoter Phyper-spank (Phs) from pDR111 (101) and the origin of 
replication from pBC16.  The atxA gene was amplified using TH191 and TH192 
(Table 2-2) to add a SalI site 5’ of the ribosome binding site (rbs, +76 from P1) and a 
SphI site after the translational stop codon.  The resulting plasmid (pUTE658) 
contains atxA controlled by Phs.   
“I used a comparable strategy to clone the gfp-mut3a sequence (111) into 
pUTE657, yielding pUTE1013. Using TH193 and TH234 (Table 2-2), the gfp-mut3a 
sequence was PCR amplified from pAD123 (112) to include the ribosome binding site 
and to add a C-terminal FLAG tag to gfp-mut3a.” (102) 
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I constructed B. anthracis strains carrying Phs –controlled atxA alleles on pUTE657 to 
allow expression of carboxy-terminal epitope-tagged parent and mutant AtxA proteins. 
Mutant alleles were generated using PCR-SOE and appropriate oligonucleotide primers 
(Table 2-2).  For carboxy-terminal epitope tags (FLAG and hexa-His), primers were designed 
to encode the desired tag at the 3’ end of atxA prior to the stop codon.  To create 5’ deletions 
of atxA, oligonucleotides fused the rbs of atxA to codon 167 or 385 (TH254 or TH247).   For 
3’ deletions of atxA, a FLAG-tag and stop codon were inserted after the 164th or 385th codon 
(TH257 or TH260).  AtxA-GFP-FLAG fusions were created using PCR-SOE to connect the 
385th (TH267 and TH268) or 475th codons (TH212 and TH213) of atxA to the gfp-mut3a 
sequence containing a carboxy-terminal FLAG tag.  Each of the atxA alleles was cloned into 
the SalI and SphI sites of pUTE657.  In total, I produced six vectors (AtxA truncations): 
pUTE1018-FLAG (AtxA1-164-FLAG), pUTE1019-FLAG (AtxA1-385-FLAG), pUTE1020-GFP-
FLAG (AtxA167-385-GFP-FLAG), pUTE1021-GFP-FLAG (AtxA167-475-GFP-FLAG), pUTE1022-
FLAG (AtxA385-475-FLAG), and pUTE1022-GFP-FLAG (AtxA385-475-GFP-FLAG) (Table 2-1). 
 To express proteins within B. anthracis, I inserted genes of interest into the pUTE657 
vector.  The ptsHI genes were amplified using MT10 and MT13 and subsequently cloned into 
the SalI and SphI sites of pUTE657.  The resulting vector (pUTE1034, Table 2-1), was used 
as a template to generate an amino-terminal hexa-His tagged HPr in pUTE657 (pUTE1032).  
Using a primer upstream of Phs on pUTE657 (TH195) and TH286, I added the hexa-His tag 
after the rbs and start codon of ptsH.  Using PCR-SOE the product was combined with 
sequences representing the entire coding region, minus the start codon, of ptsH (TH287 and 
TH288).  Similarly, the ptsI open reading frame was cloned into pUTE657.  Oligonucleotides 
MT12 and MT13 amplified the region and contained the enzyme restriction sites to clone the 
sequence into pUTE657.  The construct served as the template to create an amino-terminal 
fusion of the His6 tag and ptsI.  The rbs and start codon were added to the hexa-His tag 
using TH195 and TH289.  The remaining ptsI sequence was amplified using TH290 and 
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MT13.  The two DNA products were connected using PCR-SOE.  The vector encoding the 
His-tagged EI is pUTE1040.  
 
2.3 AtxA-His purification 
“The recombinant epitope-tagged protein AtxA-His was purified from B. 
anthracis using affinity chromatography. B. anthracis UT376 (pUTE658) was cultured 
in 2-L baffled flasks containing 750 ml CACO3. Following induction with 50 µM IPTG, 
cells were harvested using centrifugation at 6200 x g for 10 min at 4° C.  Cells were 
resuspended in 3 ml Binding Buffer (5 mM imidazole, 0.5 M NaCl, 5 mM β-
mercaptoethanol, 20 mM Tris pH 7.2,) supplemented with 1X EDTA-free Complete 
proteinase inhibitor (Roche, Indianapolis, IN), 1 mM MgCl2, and 10 units DNAse I 
(Ambion, Inc., Austin, TX).  Cells were lysed via three passages through a French 
Pressure Cell Press (SLM Instruments, Inc., Urbana, IL) and soluble material was 
obtained following centrifugation at 30,000 x g for 20 min at 4° C.  Lysates were 
added to 1 ml NTA-Ni resin (Qiagen, Hilden, Germany) in Binding Buffer (total volume 
of 10 ml) and the suspension was mixed gently for 2 h at 4° C.  The resin was 
washed in batch three times with 4 ml of Binding Buffer and once with 4 ml of Wash 
Buffer 1 (40 mM imidazole pH 7.9, 1.0 M NaCl, 20 mM Tris pH 7.2, 5 mM β-
mercaptoethanol). The resin was transferred to a gravity column and washed 
sequentially with (1) 10 ml Wash Buffer 1, (2) 1.5 ml Wash Buffer – High Salt (40 mM 
imidazole pH 7.9, 1.5 M NaCl, 20 mM Tris pH 7.2, 5 mM β-mercaptoethanol), (3) 2.5 
ml Wash Buffer 1, (4) 1.5 ml Wash Buffer 2 (75 mM imidazole pH 7.9, 1.0 M NaCl, 20 
mM Tris pH 7.2, 5mM β-mercaptoethanol), and (5) 2.5 ml Wash Buffer 1.  Upon 
addition of 7.5 ml Elution Buffer (20 mM Tris pH 7.2, 800 mM imidazole pH 7.9, 500 
mM NaCl, 5 mM β-mercaptoethanol), 250 µl fractions were collected in 1.5-ml tubes 
containing 250 µl Collection Buffer (20 mM Tris pH 7.2, 150 mM NaCl, 10% glycerol, 
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5 mM EDTA, 5 mM β-mercaptoethanol).  Protein concentration and purity of the 
fractions were assessed using the Bradford reagent (Bio-Rad, Hercules, CA) and 
SDS-PAGE with Coomassie staining (1% coomassie brilliant blue, 10% acetic acid, 
40% methanol). Fractions containing AtxA-His were pooled and dialyzed in 400 mM 
NaCl, 5% glycerol, 20 mM Tris pH 7.2, and 5 mM dithiothreitol (DTT).” (102) 
 
2.4 α-AtxA Antibody and AtxA Western blots 
“Antiserum for Western blotting was raised in rabbits (Cocalico Biologicals, 
Inc., Reamstown, PA). AtxA-His, purified from E. coli using a method similar to that 
described above, was injected into rabbits and serum was collected on day 56. To 
remove non-specific antibodies, the serum was adsorbed to an immobilized E. coli 
lysate (Thermo Scientific) using the manufacturer’s protocol. IgG in the serum was 
purified using Pierce Nab Spin Columns (Thermo Scientific). 
“B. anthracis cell lysates for Western blotting analysis were obtained from 
cultures at early stationary phase (OD600 = 1.2 to 1.7). Culture samples (4 ml) were 
centrifuged as described above. After washing cells two times in KTE-PIC (10 mM 
Tris-HCl pH 8.0, 100 mM KCl, 10% ethylene glycol, and EDTA-free Complete 
proteinase inhibitor), cells were resuspended in KTE-PIC to a final volume of 850 µl 
and transferred to a 1.5-ml screw-cap tube containing 400 µl 0.1 mm Zirconia/Silica 
Beads (BioSpec Products, Bartlesville, OK).  The samples were lysed mechanically 
for 2 min using a Mini BeadBeater (BioSpec Products). After centrifugation, soluble 
material was mixed with SDS loading buffer (final concentration of loading buffer was 
5% glycerol, 100 mM DTT, 2% SDS, 40 mM Tris-Cl pH 6.8), boiled, and subjected to 
sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (SDS-PAGE). 
“Prior to protein transfer, gels were equilibrated in CAPS Buffer (10 mM CAPS 
pH 11.0, 10% methanol).  Using a Hoefer transfer unit (Hoefer, Inc., Holliston, MA) 
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containing CAPS Buffer, proteins were transferred to Immobilon-P membrane 
(Millipore, Billerica, MA) at 50V at 4° C for 1.5 to 2 h.  Membranes were blocked with 
TBS-T (20 mM Tris base, 137 mM NaCl, 0.1% Tween 20 [pH 7.6]) containing 5% 
non-fat dry milk.  Membranes were subsequently treated with primary antibodies (α-
AtxA, α-RNA polymerase β subunit [Santa Cruz Biotechnology, Santa Cruz, CA], α-
THE His [Genscript, Piscataway, NJ], and α-FLAG M2 [Sigma Aldrich]) in TBS-T. 
After washing with TBS-T, membranes were finally treated with the corresponding 
secondary antibody (goat α-rabbit–HRP conjugate or goat α-mouse-HRP conjugate 
[Bio-Rad]). Blots were developed using the SuperSignal West Dura 
Chemiluminescent Substrate (Thermo Scientific).  For re-probing, membranes were 
stripped using Restore Western Blot Stripping Buffer (Thermo Fisher) or 62.5 mM Tris 
pH 6.8 containing 2% SDS and 100 mM β-mercaptoethanol.” (102)   
 
2.5 Limited Proteolysis 
 AtxA-His was cleaved with trypsin and chymotrypsin.  30 µg AtxA-His was combined 
with 0.3 µg trypsin or chymotrypsin in 100 mM Tris-Cl pH 8.5, 1 mM CaCl2.  The digestion 
reaction was incubated at 25° C for 4 h and quenched by adding 190 mM Tris-Cl pH 6.8, 4.3 
M β-mercaptoethanol, 6% SDS, 3 mM PMSF and boiling for 3 min.  AtxA-His fragments were 
separated via electrophoresis through 16% polyacrylamide-SDS gels and detected with 
Coomassie stain.  The 40-kDa band was excised from the gel and digested to completion 
with trypsin.  The polypeptide fragments were identified via mass spectrometry in the 
laboratory of William Dubinsky at the University of Texas Health Science Center – Houston.  
A similar experiment was performed except the proteins were transferred to a PVDF 
membrane in 10 mM Tris Base, 100 mM glycine, 10% methanol.  I stained the membrane 
with 0.1% Coomassie, 40% methanol, and 10% acetic acid and destained with 40% 
methanol.  The amino-terminus of the major cleavage product was identified via Edman 
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Degradation and N-terminal sequencing by Richard Cook at the Baylor College of Medicine 
Protein Chemistry Core Facility. 
 
2.6 Filter Binding Assay 
 The affinity of AtxA-His for 32P-labeled DNA probes was determined using a filter 
binding assay similar to established protocols (113).  Promoter regions of the lef (167 bp), 
bla1 (267 bp), and papR (169 bp) genes were digested from pUTE749, pUTE756, and 
pUTE757, respectively (58), using XbaI and SalI.  The probes were dephosphorylated during 
a reaction with calf intestinal alkaline phosphatase, PNK-treated to label with γ-32P-ATP, and 
isolated with Micro Bio-Spin 30 Chromatography columns (Bio-Rad) according to the product 
manuals.   
The DNA probes (3 pM) and purified AtxA-His (0.01 nM, 0.1 nM, 0.3 nM, 1 nM, 2 nM, 
5 nM, 10 nM, 20 nM, 50 nM, 100 nM, 300 nM, and 1000 nM) were diluted in 10 mM Tris-Cl 
pH 7.5, 150 mM KCl, 5 mM MgCl2, 5 mM DTT, 3% glycerol, and 0.1 mg ml
-1 bovine serum 
albumin (BSA).   In a 96-well plate, 220 µl reactions were prepared in triplicate.  Protein and 
DNA solutions were incubated at room temperature for 30 min.  A nitrocellulose filter 
membrane was pre-wetted in 150 mM KCl, 10 mM Tris-Cl pH 7.5, 5 mM MgCl2, and 3% 
glycerol and placed within a 96-well vacuum manifold. Aliquots of 150 µl of the reaction were 
applied to the filter.  Subsequently, the filter was dried at 37° C and protein-32P-labeled DNA 
complexes were detected via phosphor-imaging screen (Fujifilm, Tokyo, Japan).  The images 
were scanned via a STORM imager (Amersham Pharmacia Biotech, Piscataway, NJ) and 
the intensity of each sample was quantified via ImageQuant software (Amersham Pharmacia 
Biotech).  The signal intensity minus the background of triplicate samples was averaged and 
then normalized to the sample containing 1000 nM AtxA-His. 
When varying the KCl concentration or pH, the experiment was performed as 
described except with minor modifications.  Only 0.2 nM, 20 nM or 200 nM AtxA-His was 
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assayed in each condition.  The membranes were pre-wetted with buffer containing the 
lowest salt concentration or lowest pH.  Before applying the samples to the filter, the wells of 
the vacuum manifold were rinsed with buffer of the corresponding sample. 
 
2.7 BN-PAGE assay 
“To perform Blue Native polyacrylamide gel electrophoresis (BN-PAGE), 
protein samples mixed with NativePAGE Sample Buffer containing 5% G-250 Sample 
Additive were electrophoresed using NativePAGE Novex 4-16% Bis-Tris Gels in the 
XCell Surelock Mini-Cell electrophoresis unit according to the manufacturer’s 
instructions (Invitrogen, Carlsbad, CA). Electrophoresed proteins were transferred to 
PVDF at 20V overnight at 4° C. Blots were fixed with 8% acetic acid for 15 min prior 
to probing with α–AtxA antibody as described above.”  (102) 
 
2.8 Co-affinity purification 
“B. anthracis UT376 containing vectors encoding AtxA-His (pUTE991), AtxA-
FLAG (pUTE992), or GFP-FLAG (pUTE1013) were cultured independently. Three 
pools, containing 20 ml of each culture, were collected:  UT376 (pUTE991) and 
UT376 (pUTE1013); UT376 (pUTE991) and UT376 (pUTE992); and UT376 
(pUTE992) and UT376 (pUTE1013). The cells were washed with 10 ml Binding Buffer 
containing EDTA-free Complete proteinase inhibitor (BB-PIC).  Pellets were flash 
frozen in an ethanol-dry ice bath and stored at -80° C. 
“To create cleared soluble cell lysates, samples were thawed in an ice bath, 
resuspended in 2.5 ml BB-PIC, and transferred to two 1.5-ml screw cap tubes, each 
containing 500 µl 0.1 mm Zirconia/Silica beads. The samples were lysed 
mechanically for 1 min using a Mini BeadBeater, placed on ice for 5 min, and then 
subjected to an additional 1 min of bead beating.  Following centrifugation at 10,000 x 
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g for 5 min at 4° C, the soluble material was incubated at 37° C for 20 min.  NTA-Ni 
resin (70 µl) was added and the samples were incubated at 4° C for 2 h. The resin 
was transferred to spin filters (EMB Chemicals, Darmstadt, Germany) and several 
500-µl washes were performed in the following sequence: 2x Binding Buffer, 2x Wash 
Buffer 1, 1x Wash Buffer-High Salt, 2x Wash Buffer 1, 1x Wash Buffer 2, and 2x 
Wash Buffer 1. Proteins were eluted from the column using 125 µl Elution Buffer and 
then denatured with SDS loading buffer.  Samples were probed with α-AtxA, α-His, 
and α-FLAG antibodies using Western blotting.” (102)   
 
2.9 BMH Cross-linking 
“Protein cross-linking was performed as described elsewhere (114).  Briefly, 
cultures containing UT376 (pUTE658) were induced with 30 µM IPTG for 2 h. Cells 
were washed twice with 5 ml phosphate-buffered saline (PBS) containing 10 mM 
EDTA and adjusted to pH 7.2.  Cells were then resuspended in 1 ml PBS 10 mM 
EDTA pH 7.2 and lysed.   For each experiment, 250 µl of cleared soluble cell lysate, 
representing 5 ml of culture, was mixed with 5 µl of 20 mM bis(maleimido)hexane 
(BMH, Thermo Scientific, prepared freshly in DMSO) and incubated at 4° C for 2 h 
with end-over-end mixing. Control reactions lacking BMH contained the DMSO 
solvent only. Reactions were quenched by adding 40 mM cysteine, vortexing for 10 
min, and boiling in the presence of 1X SDS loading buffer containing 100 mM DTT.  
The samples were analyzed on 4-15% polyacrylamide SDS gels (Bio-Rad) and AtxA 
was detected via Western blotting. ImageJ software (115) was used to determine 
relative intensities of cross-reactive bands. 
“AtxA-His for cross-linking experiments was affinity purified using NTA-Ni resin 
and washes were performed with solutions made without β-mercaptoethanol.  AtxA-
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His was eluted from the resin, and subjected to BMH cross-linking as described 
above.” (102)  
 
2.10 Purification of EI, HPr, and PEPCK 
 EI-His and HPr-His were isolated separately from B. anthracis following previously 
published methods (116, 117).  Two 2-L baffled flasks containing 500 ml LB medium 
inoculated with an eight-hour culture of ANR-1(pUTE1032) or ANR-1(pUTE1040) were 
incubated at 37° C.  During late exponential phase of growth (OD600 = 0.6 – 0.8), the cultures 
were induced with 0.5 mM IPTG at for four hours.  Cell pellets were frozen after harvesting 
via filtration onto a nitrocellulose membrane (0.22 µm pore-size) and centrifugation at 6200 x 
g for 10 min at 4° C.  Each cell pellet was resuspended in 10 ml Buffer A-PIC (20 mM Tris-Cl 
pH 8.0, 100 mM NaCl, 5% glycerol, 30 mM imidazole pH 7.9, 1X EDTA-free Complete 
proteinase inhibitor cocktail) supplemented with 1 mM MgCl2 and 10 units DNAse I.  Cells 
were lysed via three passages through a French Pressure Cell Press and soluble material 
was obtained following centrifugation at 30,000 x g for 20 min at 4° C.  Lysates were added 
to 1 ml NTA-Ni resin in Buffer A-PIC (total volume of 10 ml) and the suspension was mixed 
gently for 2 h at 4° C.  The resin was washed in batch three times with 4 ml of Buffer A-PIC. 
The resin was transferred to a gravity column and washed with 5 ml Buffer A-PIC.  Upon 
addition of 5 ml Buffer E (20 mM Tris-Cl pH 8.0, 100 mM NaCl, 5% glycerol, 200 mM 
imidazole pH 7.9), 500 µl fractions were collected.  Protein concentration and purity of the 
fractions were assessed using the Bradford reagent and SDS-PAGE with Coomassie 
staining. Fractions containing EI-His or HPr-His were pooled, concentrated, and desalted 
using Microcon centrifugal concentrators (Millipore).  The proteins were stored at 4° C in 50 
mM Tris-Cl pH 7.4, 5 mM MgCl2, 5% Glycerol. 
 PEP carboxykinase (His-PEPCK) was expressed and purified from the E. coli strain 
C41(DE3) harboring plasmid pKSM879 (gift from K. McIver, University of Maryland).  A 
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colony of the strain was used to inoculate three 2-L baffled flasks each containing 500 ml 
ZYP-5052 autoinduction medium (118).  The cells were cultured at 37° C for 24 hours.  After 
harvesting cells via centrifugation (10 min, 6200 x g, 4° C), the cell pellet was washed twice 
with 50 ml 100 mM NaH2PO4 pH 8.0 and stored at -80° C.  The cell pellet was resuspended 
in 35 ml Buffer 1 (20 mM imidazole, 20 mM NaH2PO4, 500 mM NaCl, pH 7.4) containing 
Complete EDTA-free proteinase inhibitor and cell membranes were ruptured during five 
passages through a French Pressure Cell.  The sample was centrifuged at 6200 x g at 4° C 
for 10 min.  The soluble material was transferred to a new tube and centrifuged for 20 min at 
20,000 x g and 4° C before applying to 2 ml NTA-Ni resin prewashed with Buffer 1.  After 
binding for 1 h at 4° C, the resin was washed in batch using 8 ml Buffer 1.  The resin was 
transferred to a gravity-flow column and subsequently washed with 25 ml Buffer 1.  PEPCK 
was eluted from the resin with 10 ml Buffer 2 (500 mM imidazole, 20 mM NaH2PO4, 500 mM 
NaCl, pH 7.4).  20 µl Ni chelation buffer (250 mM EDTA, 50 mM NaH2PO4) was added per ml 
fraction and fractions containing His-PEPCK were dialyzed four times against 1 L Buffer 3 
(20 mM Tris-Cl pH 7.4, 1 mM EDTA, 100 mM KCl).  The induction and purification yielded 
100 mg His-PEPCK. 
 
2.11 Synthesis of 32P-PEP 
 32P-PEP was synthesized and isolated according to methods established previously 
(119) using γ-32P-ATP (PerkinElmer, Waltham, Massachusetts) and PEPCK.  0.5 ml 
reactions containing 50 mM HEPES pH 7.5, 12.5 mM KF, 5 mM MgCl2, 1 mM oxaloacetate, 
500 µg PEPCK, 50 µM γ-32P-ATP (2 mCi ml-1, 10 Ci mmol-1) were incubated for 5 min at 
room temperature (21° C).  The reaction was diluted 10-fold with ddH2O, and the newly 
synthesized 32P-PEP was isolated via anion exchange chromatography using AG-1-X8 
Bicarbonate resin.  The hydroxide form of the AG-1-X8 resin (BioRad) was converted to the 
bicarbonate form according to the product manual.   The PEP reaction was added to 2 ml of 
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resin and 32P-PEP was eluted using a step-wise gradient consisting of 5 ml 0.3 M, 0.4 M, 0.6 
M, and 0.7 M triethylammonium bicarbonate.  32P-PEP was present in fractions containing 
0.6 M and 0.7 M triethylammonium.  The fractions were concentrated 5 fold via vacuum 
centrifugation in a vacufuge (Eppendorf, Hamburg, Germany).   
 
2.12 In vitro Phosphotransfer Assay 
 Phosphotransfer assays were conducted using purified EI-His, HPr-His, and AtxA-
His.  Reactions contained 3 µg EI-His, 1.6 µg HPr-His, 2 µg AtxA-His in a total volume of 30 
µl buffer (50 mM Tris-Cl pH 7.4, 5 mM MgCl2). 
32P-PEP (0.5 µCi, 10 Ci mmol-1) was added to 
a final concentration of 10 µM and the solutions were incubated for 30 min at 37° C. 
Reactions were quenched by adding SDS loading buffer (final concentration of loading buffer 
was 5% glycerol, 100 mM DTT, 2% SDS, 40 mM Tris-Cl pH 7.4).  Samples were subjected to 
SDS-PAGE (12% poly-acrylamide SDS gel).  The gels were dried and exposed to phosphor-
imaging screen to detect 32P-labeled protein.  The screens were scanned using a STORM 
840 scanner and analyzed with ImageJ software. 
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Chapter III 
Analysis of the domains and DNA binding properties of AtxA, the 
virulence gene regulator of B. anthracis. 
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3.1 Introduction 
 B. anthracis virulence gene regulation requires AtxA, a protein encoded on the 
extrachromosomal virulence plasmid pXO1.  In atxA mutant strains, toxin gene expression 
and capsule biosynthesis, the major B. anthracis virulence traits, are decreased severely and 
the organism is attenuated (46, 47, 49–54).  The molecular function of AtxA is unknown; 
however, a model has been proposed that AtxA contains two functional regions (60).  The 
amino-terminus of AtxA is predicted to bind DNA promoters via two putative DNA-binding 
elements.  DNA-binding activity of AtxA is controlled via structural changes occurring within a 
regulatory region containing the carboxy-terminal PRDs and EIIB-like motifs (AtxA motifs are 
introduced in section 1.4).  
The amino acid sequence of AtxA indicates that two types of helix-turn-helix motifs 
are present within the putative DNA-binding region: a winged helix-turn-helix (WH) and a 
classical helix-turn-helix (HTH).  HTH motifs are the most common DNA-binding modules 
used in bacteria (120).  Consisting of approximately 20 amino acids, HTH motifs contain two 
α-helices separated by a four-residue loop creating a 120° turn (121).  The second helix is 
the recognition helix which binds the major groove of DNA forming base-specific contacts 
(122).  Mutations in the recognition helix can disrupt DNA binding without altering the stability 
of the protein (91).  The prototypical WH is arranged H1-S1-H2-H3-S2-W1-S3-W2.   The 
HTH in the WH is H2 and H3, while the wings (W1 and W2) are loops which form between 
and after anti-parallel β sheets (S2 and S3) (123).  The wings can contact the phosphate 
backbone or make specific hydrogen bonds to the DNA.  There are examples of the wings 
facilitating protein-protein interactions (124, 125).  Interestingly, WH motifs are known to 
undergo disorder-to-order shifts when small molecule cofactors are present (126).   The 
classical HTH within AtxA has strong similarity to HTH-4 of Mga (see section 1.6 for an 
introduction to Mga).   Mga HTH-4 binds specifically to DNA probes in electrophoretic 
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mobility shift assays (90, 91).  Even with two putative DNA-binding motifs, AtxA has not been 
shown to bind specifically to target promoters.   
Most DNA-binding proteins bind to a specific nucleotide sequence; however, a few 
proteins bind to unique structural elements within the DNA (127).  The toxin gene promoters 
display no sequence similarity.  Hadjifrangiskou and Koehler (58) determined the minimal 
functional promoters for the toxin genes, pagA, lef, and cya.  No consensus sites were 
detected within these regions which ranged from 137 to 168 bp in length; however, the A+T 
content was significantly higher for the toxin gene promoters (79-85%) than the B. anthracis 
genome (64.6%, (4)).  Considering high proportions of A+T bases indicate a high level of 
DNA curvature, Hadjifrangiskou and Koehler provided in vitro and in silico evidence that the 
pagA, lef, and cya promoters form 90° bends and distinct kinks.  Given this information, AtxA 
may bind to a structural feature within the DNA and not a specific sequence. 
One way to study protein-DNA interaction and the function of individual motifs within 
a protein is to investigate the domain organization of a protein via limited proteolysis and 
express each domain or motif independently.  LicT, a B. subtilis protein containing an RNA 
binding motif and two PRDs, was studied using limited proteolysis and protein truncations.  
Data from limited proteolysis experiments suggested there are two major domains within the 
protein (128).  When the motifs were expressed in isolation, each one was capable of 
maintaining some functional activity.  The PRDs formed a homodimer and the RNA binding 
motif bound its RNA target sequence (129).   
 In this chapter, I describe a system for over-expression of AtxA in B. anthracis that 
allowed me to uncouple transcriptional control of atxA expression from in vivo studies of 
protein function. I present results from limited proteolysis experiments suggesting protease-
resistant domains. The activity of truncated versions of AtxA, missing one or more motifs, in 
parent and atxA-null strains is assessed.  Lastly, I determine the DNA binding affinity of AtxA 
and measure the effects of KCl concentration and pH on the degree of DNA binding.  
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3.2 Results 
3.2.1 Induction of AtxA in B. anthracis 
 To study AtxA protein function in vivo, it is desirable to over-express the protein within 
B. anthracis.  The atxA gene is subject to complex transcriptional control (Fig. 1-1). 
Moreover, the amount of AtxA in each cell is low (approximately 250 proteins per cell, 
Raynor and Koehler unpublished results). To overcome these complications, I developed an 
expression system that allows controlled induction of atxA expression resulting in specific 
levels of AtxA protein. The induced protein may be purified and used for in vitro analyses or 
utilized in vivo to answer questions regarding the function of AtxA.  The inducible system was 
used in several experiments throughout my dissertation. Here I describe the expression 
pattern of AtxA when IPTG is titrated into cell cultures. I also demonstrate that the protein is 
functional when over-expressed. 
 I cloned the atxA gene downstream of the IPTG-inducible hyper-spank promoter 
(Phs) on a low-copy plasmid (pUTE657) and determined the amount of AtxA protein and 
activity gained in B. anthracis.  Phs contains 2 lacO sequences that can bind the plasmid-
encoded LacI repressor.  IPTG binds to LacI to relieve the repression and allow transcription 
of the downstream gene.  Using Phs-gfp, I determined that there was little variation in the 
amount of GFP expression within each cell in the culture indicating that IPTG activates 
transcription uniformly (data not shown). The plasmid containing Phs-atxA (pUTE658) was 
transformed into an atxA-null mutant of the ANR-1 strain harboring a Plef-lacZ transcriptional 
fusion (UT376).  During early exponential growth in toxin-inducing medium (CACO3), I added 
10-60 µM IPTG to induce expression of atxA.  Samples for AtxA Western blots and AtxA 
activity assays were collected at the transition to stationary phase (Fig. 3-1A).  AtxA activity, 
defined by the amount of β-galactosidase activity resulting from expression of the Plef-lacZ 
reporter, increased in an IPTG dose-dependent manner (Fig. 3-1B). The AtxA activity in 
cultures  induced  with  10 µM IPTG  was  similar to  the  parent  strain in  which  AtxA  was  
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Figure 3-1. AtxA activity and protein amount after induction with IPTG. 
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Figure 3-1. AtxA activity and protein amount after induction with IPTG. A. In an atxA-
null strain (UT376), production of AtxA (Phs-atxA, pUTE658) was induced (arrow, 2 h; OD600 
0.23 – 0.25) using 10 - 60 µM IPTG during growth in CACO3. The parent strain (UT375) 
contained atxA at its native locus.  The empty vector sample (EV) was derived from UT376 
(pUTE657) that lacks atxA. Samples were obtained at the transition to stationary phase 
(arrow; 4 h; OD600 1.2–1.7). B. The β -galactosidase activity of B. anthracis mutants 
harboring the Plef-lacZ reporter and IPTG-inducible atxA alleles was determined as 
described previously (130), and results from a representative experiment are shown.   The 
histograms represent the Miller Units. Values, normalized to the parent strain, are shown 
above each sample. C. AtxA and RNA Polymerase β subunit in soluble cell lysates were 
detected via immunoblotting. The AtxA levels indicated were normalized relative to the 
corresponding RNA polymerase β level.  D. The AtxA Protein Level of each sample was 
plotted in respect to the AtxA Activity.  The concentration of IPTG in each culture is present 
next to each data point.  The line of best fit is shown (R2 = 0.9959). 
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produced from its native promoter.  Inducing with 40 µM IPTG produced 4.59-fold more 
activity, the highest amount of activity detected.  Interestingly, AtxA activity did not increase 
further when 50 or 60 µM IPTG was added even though the amount of AtxA protein changed.   
AtxA protein levels increased upon IPTG addition (Fig. 3-1C).  Induction of Phs-atxA 
with 10 µM IPTG resulted in AtxA levels equal to the parent strain.  Cells produced 23.9 
times more AtxA than the parent strain when induced with 50 µM IPTG.  In other 
experiments, cells induced with 1 mM IPTG produced approximately 50-fold excess AtxA; 
however the cells stopped replicating after adding IPTG (data not shown).     
I plotted AtxA protein levels versus AtxA activity and saw a linear relationship 
between these two parameters within a defined region (10 – 40 µM IPTG, Fig. 3-1D).  These 
results demonstrated that the steady state level of AtxA can be increased 25-fold above the 
native level and that the induced AtxA is active.   
   
3.2.2 AtxA contains two large domains 
 Domain organization of the five putative motifs of AtxA is poorly understood.  The 
structure of AtxA was probed using limited proteolysis, a facile method to detect well-folded 
protein domains (131).  Proteolytic enzymes cut proteins in regions where the protease-
specific sequences are solvent-accessible and flexible.  Tightly-folded domains are resistant 
to cleavage, whereas loops between the domains are sensitive.   
I digested purified AtxA-His with trypsin and chymotrypsin.  AtxA-His was induced in 
E. coli and purified to greater than 90% homogeneity.  Trypsin cuts after lysine or arginine 
residues, and chymotrypsin cleaves primarily after aromatic amino acids.  To prevent 
complete digestion of AtxA, I incubated AtxA with a low concentration of protease.  Both 
proteases released one major product, an approximately 40-kDa fragment of AtxA (Fig. 3-
2A).  The tryptic protein fragment was identified via mass spectrometry and amino-terminal   
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Figure 3-2. AtxA contains one major protease cleavage site.  Affinity-purified AtxA-His 
was subjected to limited proteolysis with trypsin (T) and chymotrypsin (C) for 4h at 25° C.  A. 
Coomassie-stained SDS-PAGE displays the major cleavage product (*).  Full-length AtxA 
(arrow) is present in all samples, including the untreated control (UNT).  B. Using amino-
terminal sequencing, the dominant cleavage site after trypsin digest was identified as K140 
(underlined).  
  
  44 
sequencing as the last 335 amino acids of AtxA-His (AtxA141-475, Fig. 3-2B). The major site of 
cleavage for chymotrypsin was not identified; however it may be Y129, L136, L143, or F155.    
These data suggested that AtxA contains two domains.  The first domain encompassed the 
putative DNA-binding elements (AtxA1-125), while the second consisted of the PRDs and EIIB-
like motif (AtxA167-475).  The 41 amino acids between the domains (AtxA126-166) may be a 
flexible, linker region.   
 
3.2.3 The function of individual motifs of AtxA 
The results from the limited proteolysis experiments guided the construction of 
several truncated versions of AtxA.  As depicted in Fig. 3-3A, the AtxA truncations lack one 
or more motifs.  I incorporated a carboxy-terminal FLAG or GFP-FLAG tag on each 
derivative of AtxA cloned into the IPTG-inducible vector pUTE657.  FLAG-tagged proteins 
were distinct from AtxA when using the α-FLAG antibody.  GFP-FLAG added 29 kDa and 
increased the stability of the truncated versions of AtxA.  GFP also permitted the use of 
fluorescence microscopy to confirm expression of the protein.   
The fragments of atxA were expressed in a parent strain and an atxA mutant 
containing the Plef-lacZ reporter (UT375 and UT376, respectively).  After induction with 50 or 
100 µM IPTG, the proteins were soluble within the cell and present at levels similar to full-
length AtxA (data not shown).  The AtxA protein derivatives were not functional in an atxA-
null strain as no protein provided Plef-lacZ activity greater than the empty vector control (Fig. 
3-3B).  These results suggest that all the motifs were necessary for AtxA to function properly.  
The activity of native AtxA was not affected by the protein fragments with the exception of 
AtxA167-385–GFP-FLAG and AtxA167-475–GFP-FLAG (Fig. 3-3C).  Only 40% of the parent strain 
activity was detected during expression of these protein fragments, which include the PRDs.  
The data suggest that AtxA167-385–GFP-FLAG and AtxA167-475–GFP-FLAG may be dominant 
negative  and  function to titrate  a signal from AtxA.    An alternate  explanation is  that the  
  45 
 
Figure 3-3. AtxA activity of the AtxA motifs in vivo.  A.  AtxA contains five putative motifs 
as shown in the schematic.  Five truncated AtxA proteins (containing one or more of the 
motifs fused to FLAG or GFP-FLAG tags on the carboxy-terminus) were placed under the 
control of the IPTG-inducible Phs (pUTE657) to make pUTE1018-1022.  B. and C. The atxA-
null and parent strains harboring Plef-lacZ (UT376 and UT375, respectively) and the AtxA 
truncations were cultured in CACO3. Cultures were induced during early exponential phase 
and samples were collected at the transition to stationary phase for β-galactosidase activity 
assays.  Graphs show the β-galactosidase activity normalized to the AtxA-FLAG sample (B, 
ΔatxA strain) or to the empty vector (C, Parent strain).  Note the change in scale of the y-
axes.  Cartoons below each bar represent the tagged AtxA fragment induced in each 
sample.  AtxA167-385–GFP-FLAG and AtxA167-475–GFP-FLAG decrease native AtxA activity 
(blue stars).  
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fragments prevent full-length AtxA from functioning via protein-protein contacts.  Notably, 
AtxA1-385–FLAG and AtxA385-475–GFP-FLAG did not diminish AtxA activity.  Each of these 
AtxA protein truncations contains the PRDs, the EIIB-like motif, or the GFP-FLAG fusion; 
therefore, the reason for the dominant negative phenotype is unknown.  These data provide 
an initial analysis of the function of each AtxA region. 
 
3.2.4 AtxA binds DNA non-specifically 
 WH and HTH motifs indicate that AtxA binds to specific promoter elements; however, 
there does not appear to be a consensus sequence within the promoters of the AtxA-
regulated toxin genes pagA, lef, and cya (58).  To investigate if AtxA interacts directly and 
specifically with DNA, I conducted in vitro DNA-binding using filter binding assays.  A 
constant amount of 32P-labeled DNA and increasing concentrations of AtxA-His were mixed 
in Tris buffer containing 150 mM KCl at pH 7.5.  The protein, which was purified from E. coli, 
was bound to a nitrocellulose membrane, and the AtxA-DNA association equaled the 
intensity of the radioactive signal.  For DNA probes, I used a promoter from an AtxA-
regulated toxin gene (Plef), promoters from B. anthracis genes that are AtxA-independent 
(Pbla1 and PpapR), and sequence from an E. coli expression vector (pET23d).  The binding 
curves indicated that AtxA binds to all probes with high affinity and no specificity (Fig. 3-4).  
The dissociation constant (Kd) of the AtxA-DNA interaction is below 1 nM.  A low nanomolar 
Kd is significant and suggests that AtxA binds DNA in vivo.   
In order to determine if the interaction between AtxA and DNA is facilitated by ionic 
interactions, I performed DNA binding assays with different pH or KCl concentrations.  AtxA 
bound less effectively to the lef promoter and a segment of pET23d as the KCl concentration 
increased from 22 mM to 300 mM (Fig. 3-5A).  22 mM KCl promoted the greatest amount of 
AtxA-DNA interaction.  300 mM KCl abolished AtxA binding to DNA.  Lowering the pH from 
7.5  to  6.8  increased the  amount of  DNA bound  by 20  nM  AtxA (Fig. 3-5B).  AtxA-DNA   
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Figure 3-4. AtxA binds DNA non-specifically with high affinity.  Filter Binding Assays 
were used to probe the interaction between affinity-purified AtxA-His and non-specific control 
promoter sequences (Pbla1, 267 bp, and PpapR, 169 bp) or an AtxA-dependent promoter 
(Plef, 167 bp).  A six-log range of protein concentration was used with a constant amount of 
32P-labeled DNA (0.3 nM) in 150 mM KCl, 10 mM Tris-Cl, 5 mM MgCl2, 5 mM DTT, 3% 
glycerol, 0.1 mg/ml BSA, pH 7.5. The radioactive signal from triplicate reactions was 
averaged and normalized to the sample containing 1000 nM AtxA.  Error bars represent ±1 
SD.  
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interaction did not change when the pH was increased from 7.5 to 8.5 or 9.1.  Altering the 
KCl concentration or pH did not result in specific DNA binding.  AtxA bound to the target and 
control promoters with similar affinities.  These data indicate that an AtxA-DNA interaction is 
dependent on the KCl concentration; however, increasing pH of the solution above 7.5 did 
not have a great effect.   
 
3.3 Discussion 
 In this chapter, I have described the IPTG-inducible system for AtxA expression in B. 
anthracis, analysis of the domain organization and motifs of AtxA, and an initial 
characterization of the DNA binding properties of AtxA. 
 Expression of atxA using a heterologous promoter led to a 25-fold higher AtxA 
concentration and a 4.5-fold increase in Plef-lacZ expression.  Preliminary experiments 
performed by others in our laboratory indicate that there are as few as 250 AtxA molecules 
per cell when AtxA is expressed from its native promoter (unpublished 2010).  The low level 
of AtxA makes it challenging to detect the protein in B. anthracis cells. Controlling AtxA via 
an IPTG-inducible promoter allows over-expression of AtxA-His for purification, production of 
mutant forms of AtxA (point mutations and truncated versions), and induction of AtxA in 
conditions that do not favor AtxA activity.  
The relationship between AtxA protein level and AtxA activity suggests that AtxA is 
limiting for lef expression.  Induction of AtxA with 10 µM IPTG produced native levels of AtxA 
protein and activity, and a slight increase in IPTG concentration led to increased AtxA and 
Plef-lacZ expression.  Control experiments showed that IPTG did not induce expression of 
the toxin genes in the parent strain (lacks Phs-atxA).  Therefore, elevated Plef-lacZ upon the 
addition of IPTG to cells containing the Phs-atxA was due to higher AtxA protein levels.  If 
AtxA was not limiting, increased AtxA protein would not lead to higher lef transcript levels.   
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Figure 3-5. AtxA-DNA binding is sensitive to KCl concentration but not to pH. Affinity-
purified AtxA-His and Plef (167 bp) or a control DNA probe (179bp of the plasmid pET23d) 
were subjected to Filter Binding Assays.  0.2 nM, 20 nM, or 200 nM AtxA was mixed with a 
standard amount of 32P-labeled DNA (0.3 nM) in 150 mM KCl, 10 mM Tris-Cl, 5 mM MgCl2, 5 
mM DTT, 3% glycerol, 0.1 mg/ml BSA, pH 7.5. A. The concentration of KCl was changed to 
22 mM, 75 mM, 150 mM, or 300 mM.  B. AtxA-DNA interactions were probed in a Tris buffer 
at pH 6.8, 7.5, 8.5 or 9.1.  Each column represents the average radioactive signal minus the 
background signal (DNA alone) of an experiment done in duplicate. Error bars represent  ±1 
SD.   
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Although AtxA may be a limiting factor for toxin gene expression under native 
conditions, the data also suggest that AtxA does not act independently.  Soluble AtxA protein 
levels increased from 14.5 to 23.9 times the parent concentration between 40 and 50 µM 
IPTG; however, AtxA activity plateaued when cells were induced with 40, 50, or 60 µM IPTG.  
If AtxA acted independently, then I would expect AtxA activity to be highest in cultures 
induced with 50 µM IPTG.  I was not able to determine the identity of the limiting factor in the 
process when AtxA activity is at its maximum.  Two possible explanations are that Plef-lacZ 
transcription rate may be at its maximum or the cellular amount of a post-translational signal, 
ligand, or binding protein may have been exhausted. 
 The IPTG-inducible promoter allows the study of the AtxA motifs by expressing 
truncated forms of AtxA.  As I describe in the introduction (section 1.7), I favor a model in 
which AtxA contains two functional domains.  The amino-terminal region appears to bind 
DNA, and the remainder of the protein regulates the DNA binding activity.  Limited 
proteolysis supports this model: the final 335 amino acids of AtxA are resistant to digest with 
trypsin or chymotrypsin.  Due to the numerous trypsin cut sites (58 in total, 39 downstream of 
the dominant site of digestion K140), AtxA is expected to be completely digested during an 
extended reaction.  The 40-kDa product could only be present if that region of the protein 
was a well-folded domain where trypsin could not cleave.   
The protease-resistant AtxA fragment contains two PRDs and an EIIB-like motif.  
When I expressed these motifs fused to a carboxy-terminal GFP-FLAG tag (AtxA167-475–GFP-
FLAG) in an atxA-null strain, little lef expression was detected from the Plef-lacZ reporter.  In 
the parent strain, AtxA167-475–GFP-FLAG decreased the amount of AtxA activity by 60%.  
AtxA167-385–GFP-FLAG, which contains only the PRDs, displayed a similar phenotype.  These 
data suggested that while the PRDs were not capable of complementing atxA, they were 
able to produce a dominant negative phenotype in the parent strain.   
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Why were the PRDs able to cause a decrease in toxin gene expression in the parent 
strain?  One possible explanation is that the PRDs (with or without the EIIB motif) could 
complex with AtxA or another protein.  In Chapter 4, I describe experiments which indicate 
that AtxA forms a homomultimer in vivo, and I propose that the EIIB-like motif facilitates 
AtxA-AtxA interactions.  A second explanation for the dominant negative phenotype is that a 
signal was titrated from AtxA by AtxA167-385–GFP-FLAG and AtxA167-475–GFP-FLAG. The 
protein(s) that phosphorylate H199 and H379 may modify the protein fragments instead of 
full length AtxA.  In this scenario, the PRDs would serve as phosphate sinks.  Future 
experiments are needed to understand fully why AtxA167-385–GFP-FLAG and AtxA167-475–GFP-
FLAG caused a dominant negative phenotype.  One confounding factor is that AtxA1-385, 
containing the DNA binding motifs and the PRDs, did not reduce the activity of AtxA in the 
parent strain.  I speculate that AtxA1-385 does not exhibit a dominant negative phenotype 
because the DNA-binding motifs disrupt the protein-protein interaction and/or ligand binding. 
Included in AtxA1-138 are the amino-terminal WH and/or HTH which are predicted to 
bind DNA.  The protein fragment failed to complement an atxA-null strain suggesting that the 
motifs require the rest of the protein to function properly.  Alternatively, the truncation could 
have been misfolded.  Although it is unknown if AtxA1-138 binds DNA in vivo, the protein can 
be tested using the filter binding assay. 
Purified AtxA-His bound without sequence specificity to DNA with sub-nanomolar 
affinity in a filter binding assay.  The binding affinity of the AtxA-DNA interaction is quite 
significant as other specific DNA binding proteins have affinities less than 10 nM (132, 133).  
Mga and MtlR are proteins with motifs similar to AtxA and bind specifically to DNA.  MtlR 
binds to five regions spanning 45 bp upstream of the -35 consensus sequence within a target 
promoter (84).  The DNA binding affinity of MtlR changes from 3.4 nM to 1300 nM depending 
on the phosphorylation state of MtlR.  Similar to MtlR, Mga specifically binds to several 
promoters and protects a 45 bp region adjacent to the -35 consensus sequences of the emm 
  52 
and scpA6 genes (90).  The studies with MtlR and Mga suggest that specific conditions 
within the experiment (pH or salt) or mutated versions of AtxA can be determined to promote 
specific DNA binding.   
I altered the salt concentration and pH of the experiment and determined that the 
DNA binding affinity of AtxA decreased as the KCl concentration increased.  Changing the 
ionic strength of the buffer may have interfered with AtxA contacts on the phosphate 
backbone of the DNA.  Protein-phosphate interactions are DNA sequence-independent by 
nature, because any positively charged amino acid can interact with the anionic phosphate.  
However, several DNA-binding proteins contact the phosphate backbone to increase the 
stability of the protein-DNA complex (126).  My results show that disrupting the ionic 
interactions between AtxA and DNA has a major effect on the binding properties of AtxA.   
On the other hand, changing the pH of the reaction did not have a severe effect.  The 
affinity of AtxA to DNA increased at pH 6.8.  A dose-dependent binding curve was 
established independent of the pH (from 6.8 to 9.1).  This was surprising, since changing the 
pH will change the net charge of AtxA.  The isoelectric point (pI) of AtxA is predicted to be 
9.3.  The net charge of AtxA is ~14 at pH 6.8, ~12 at pH 7.5, ~ 7 at pH 8.5, and ~3 at pH 9.1.  
The pI of the DNA binding region of AtxA (residues 1-164) is 9.73; therefore the net charge of 
the region would be slightly greater than full length AtxA.  These results suggest that there 
are sequence-specific sites of AtxA-DNA interaction. 
The filter binding assays have shown that AtxA has a high affinity for DNA and that 
the AtxA-DNA affinity can be altered with KCl, but not pH.  However, AtxA bound to DNA 
non-specifically in this assay.  As you will see in the coming chapters, AtxA forms a 
multimeric structure in specific growth conditions (elevated CO2/bicarbonate) and 
phosphorylation of AtxA affects the activity of AtxA.  Could a ligand or post-translational 
modification be needed for AtxA to interact to only its target promoters?  Future experiments 
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should use AtxA point mutations that mimic phosphorylation and utilize buffer conditions that 
contain potential AtxA ligands. 
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Chapter IV 
The B. anthracis virulence regulator AtxA: oligomeric state,  
function, and CO2-signaling 
 
 
 
 
 
 
 
 
 
 
 
NOTE:  This chapter is derived from work that, for the most part, has been published in 2011: 
“The Bacillus anthracis virulence regulator AtxA: oligomeric state, function, and CO2-
signaling.” Molecular Microbiology 82(3): 634-47 PMID:21923765. I am the primary author on 
this paper.  I performed all experiments described in this chapter.  I have received permission 
by the publisher of Molecular Microbiology, John Wiley and Sons, to reproduce all of the 
manuscript in print or electronically for the purposes of my dissertation (License Number: 
2796030226674) 
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4.1 Introduction 
 Regulation of protein function can occur in the form of modulation between a non-
active state and an active form of the protein.  In several cases, the transition between each 
state is mediated via post-translational modification and/or ligand binding which induce 
changes to the protein structure.  Protein multimerization may result from the altered 
structure.  Understanding the forms of a protein in vivo provides clues to the function of the 
protein and the mechanism(s) needed to activate the protein.  For example, dimerization of 
the PRD-containing proteins, LicT and BglG, is affected by phosphorylation (79, 80, 128, 
134).  LicT, when phosphorylated within PRD2, forms a homodimer due to stabilization of the 
complex via salt bridges forming between the phosphohistidine residues and two arginines 
(135).  Conversely, phosphorylation of PRD1 prevents dimerization via electrostatic repulsion 
between the phosphohistidines and a glutamic acid residue.  The regulation of the form and 
function of LicT provides the impetus for me to study the multimeric state of AtxA, the PRD-
containing virulence gene regulator of B. anthracis. 
“The molecular basis for AtxA function as a positive regulator of B. anthracis 
virulence genes has not been established. As described in section 1.4, the amino 
acid sequence of AtxA reveals a number of motifs associated with potential functional 
domains. The amino terminal region of the protein contains adjacent winged helix and 
helix-turn-helix (HTH) motifs. The central region of the AtxA amino acid sequence 
reveals motifs suggesting two phosphoenolpyruvate:carbohydrate phospho-
transferase system (PTS) regulation domains (PRDs). PRDs are generally found in 
bacterial proteins that function to activate or anti-terminate transcription of genes 
involved in the metabolism of specific carbohydrates (73). Transcriptional profiling 
studies have not revealed AtxA targets associated with catabolism (57), but 
Tsvetanova et al. (59) reported that phosphorylation of specific histidine residues, 
H199 and H379, each within a PRD, impacts AtxA activity. 
  56 
“A key host-related signal associated with AtxA-regulated gene expression is 
CO2/bicarbonate. Growth of B. anthracis in 5% or greater atmospheric CO2 in 
buffered medium results in elevated transcription of the toxin, capsule, and other 
AtxA-regulated genes (47, 49, 50, 69–71). Some studies suggest that the 
CO2/bicarbonate effect on toxin genes occurs in an atxA-dependent manner (47, 54, 
64, 72), yet the signal does not appear to significantly affect steady state levels of 
atxA transcript or AtxA protein (64, 95). Moreover, a protein-ligand relationship 
between CO2/bicarbonate and AtxA has not been established, nor have additional 
proteins associated with AtxA function been identified. 
“In this chapter I provide data indicating that AtxA exists in a homo-oligomeric 
state and that AtxA-AtxA contacts occur within a previously uncharacterized carboxy-
terminal EIIB-like motif. I also show a correlation between growth in elevated 
CO2/bicarbonate, the steady state level of AtxA multimer, and AtxA activity.” (102) 
 
4.2 Results 
4.2.1 AtxA activity in vivo 
“AtxA is a cytoplasmic protein with a predicted MW of 55.6 kDa (46). Some 
functional domains have been postulated (59, 60); however, the structure of AtxA has 
not been solved.  Moreover, the multimeric state of AtxA in vivo and whether AtxA 
associates with other B. anthracis proteins, have not been discerned.  
“Expression of the atxA gene is highly regulated. Therefore, to investigate 
AtxA form and function in vivo, I developed a system to control AtxA protein levels 
and quantitatively assess AtxA activity in B. anthracis. Alleles of atxA encoding native, 
mutant, and C-terminal epitope-tagged versions of the protein were cloned such that 
expression was under control of the IPTG-inducible hyper-spank promoter on a low 
copy number plasmid, pUTE657. Recombinant epitope-tagged proteins, AtxA-His and 
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AtxA-FLAG, facilitated immuno-detection and purification from B. anthracis. AtxA 
positively controls transcription of multiple genes in B. anthracis, although a direct 
interaction of the AtxA protein with promoters of target genes has not been 
demonstrated. One of the genes most strongly regulated by AtxA is lef, encoding the 
lethal factor protein, a component of the anthrax toxin (57). Plasmids bearing IPTG-
inducible atxA alleles were introduced into a B. anthracis strain (UT376) which 
harbors a markerless deletion of atxA and a transcriptional reporter, Plef-lacZ, at the 
native lef locus on pXO1. AtxA activity was quantified by measuring β-galactosidase 
activity following IPTG induction of the atxA alleles. 
“Strains were cultured in CACO3 in a 5% CO2 atmosphere, conditions shown 
previously to be conducive for atxA-controlled toxin gene expression (49). Figure 4-1 
shows relative AtxA levels and activities in B. anthracis cultures expressing native 
AtxA, AtxA-His and AtxA-FLAG. RNA polymerase β subunit was used as a loading 
control. Induction with 30 µM IPTG yielded levels of epitope-tagged proteins that were 
comparable to untagged AtxA (Fig. 4-1A), indicating that protein stability was 
unaltered by the C-terminal His- and FLAG-tags. The cultures also displayed similar 
levels of β-galactosidase activity (Fig. 4-1B), indicating that the recombinant proteins 
do not exhibit altered function. The amount of induced AtxA is 8.5-fold greater than 
the level of AtxA expressed from its native promoter on pXO1 and results in 3-fold 
more β-galactosidase activity (data not shown).  Notably, expression of the Plef-lacZ 
fusion in the atxA-null strain containing the empty vector (pUTE657) was barely 
detectable, confirming previous reports that transcriptional control of the lef gene is 
highly dependent upon AtxA (46, 49).” (102)   
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Figure 4-1. In vivo activity of AtxA-His and AtxA-FLAG. In an atxA-null strain (UT376), 
production of AtxA (pUTE658), AtxA-His (pUTE991) and AtxA-FLAG (pUTE992) was 
induced using 30 µM IPTG during growth in CACO3. The empty vector sample (EV) was 
derived from UT376 (pUTE657) that lacks atxA. Samples were obtained at the transition to 
stationary phase (4 h; OD600 1.2–1.7). A. AtxA and RNA Polymerase β subunit in soluble 
cell lysates were detected via immunoblotting. The AtxA levels indicated were normalized 
relative to the corresponding RNA polymerase β level. B. The β -galactosidase activity of B. 
anthracis mutants harboring the Plef-lacZ reporter and IPTG-inducible atxA alleles was 
determined as described previously (130). Error bars represent  ±1 SD.     
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4.2.2 Multimerization of AtxA 
“In vivo AtxA – protein interactions are of interest because DNA-binding 
proteins and proteins containing PRDs often function as dimers (79, 80, 126, 128, 
134). Furthermore, some investigations have suggested that an additional factor is 
required for AtxA function (47, 59). To explore possible protein-protein interactions, I 
subjected lysates from B. anthracis strains producing native AtxA to Blue Native 
PAGE (BN-PAGE) to determine the migration pattern of AtxA in native conditions.  
Electrophoresed proteins were transferred to membranes and probed with α-AtxA 
antibody.  The mobility of immuno-reactive bands relative to molecular weight 
markers suggested that AtxA was in a complex (Fig. 4-2A). 
“To test for stable interactions between AtxA and other cytosolic proteins, I 
subjected cell lysates of B. anthracis cells producing AtxA-His to affinity purification 
using NTA-Ni resin.   Purified AtxA-His was analyzed using BN-PAGE and denaturing 
PAGE. Western hybridization using α-AtxA serum revealed three major bands 
migrating at approximately 110 kDa, 225 kDa, and > 225 kDa and a minor band 
migrating at approximately 60 kDa (Fig. 4-2A). In contrast, Coomassie staining after 
SDS-PAGE revealed only one band in the AtxA-His eluate and its gel mobility was 
consistent with the size of an AtxA-His monomer (56 kDa) (Fig 4-2B). Since no other 
proteins were detected in the AtxA-His eluate via SDS-PAGE and the protein 
mobilized as multiple species on BN-PAGE, these results suggested that AtxA forms 
multiple homomeric complexes in cell lysates.    
“To detect association of two or more monomers of AtxA, I combined culture 
lysates of B. anthracis strains producing AtxA-His or AtxA-FLAG and used affinity 
chromatography to purify AtxA-His. A lysate from a B. anthracis strain producing 
GFP-FLAG was used as a control. Lysates were derived from pools of cultures 
containing (1) AtxA-His and GFP-FLAG, (2) AtxA-His and AtxA-FLAG, and (3) AtxA-  
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Figure 4-2. Oligomeric states of AtxA. (A) Lysates from B. anthracis strains UT376 
(pUTE657) and UT376 (pUTE658), containing an empty vector (EV) and IPTG-
inducible atxA respectively, and affinity-purified AtxA-His were electrophoresed on BN 
polyacrylamide gels. AtxA protein was detected using Western blotting. M = molecular 
weight markers (ProSieve Unstained Protein Marker, VWR). (B) Affinity purified AtxA-
His from B. anthracis UT376 (pUTE991) was subjected to SDS-PAGE and stained 
with Coomassie. M = molecular weight markers (SeeBlue Plus2 Pre-Stained 
Standard, Invitrogen). 
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FLAG and GFP-FLAG. Proteins were captured using NTA-Ni resin, eluted with 
imidazole, and detected by Western blotting. As shown in Figure 4-3 (lanes 1-3), prior 
to affinity purification each tagged protein was detected in the appropriate pools. 
Eluates from NTA-Ni resin are shown in lanes 4-6. AtxA-FLAG was detected in the 
eluate only when combined with AtxA-His (lane 5). GFP-FLAG served as a negative 
control to ensure that non-specific proteins were washed from the NTA-Ni resin and 
that the His and FLAG tags did not interact. These results demonstrate that AtxA-His 
and AtxA-FLAG form a stable complex in vitro. Considering these data and the results 
from BN-PAGE, I conclude that AtxA self-associates to form dimers, tetramers, and 
higher MW species.” (102) 
 
4.2.3 Role of the carboxy-terminal region of AtxA in multimerization   
“To further explore the properties of AtxA multimerization, I tested for the 
ability of the cross-linking reagent BMH to covalently fix AtxA complexes in cell 
lysates. BMH reacts specifically and irreversibly to link cysteine residues within 13Å.  
AtxA has cysteine residues at positions 96, 161, 202, 356, 370, and 402 (Fig. 4-5A). A 
cell lysate from an IPTG-induced culture expressing AtxA was treated with BMH, 
subjected to SDS-PAGE, and probed for AtxA via Western blot (Fig. 4-4).  Two bands 
were detected slightly above the 98-kDa marker when the lysate was treated with 
BMH (lane 6), while a single band near the 50-kDa marker was detected in an 
untreated lysate (lane 2). The predicted molecular weight of AtxA is 55.6 kDa; 
therefore, the approximately 100-kDa bands may represent two AtxA proteins joined 
via BMH. The appearance of the doublet band indicates two separate AtxA 
complexes present in the cross-linked lysate. To investigate the composition of the 
protein complexes, I affinity purified AtxA-His from an atxA-null strain and subjected 
the protein to BMH cross-linking. The migration pattern of cross-linked, purified AtxA- 
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Figure 4-3. Specific binding of AtxA-His to AtxA-FLAG. Lysates from B. anthracis atxA-
null strains (UT376) containing AtxA-His (pUTE991), AtxA-FLAG (pUTE992), or GFP-FLAG 
(pUTE1013) induced with 30 µM IPTG were subjected to co-affinity purification using NTA-Ni 
resin.  Western blots probed with α-AtxA, α-FLAG, and α-His antibodies were performed on 
soluble cell lysates (Load, lanes 1-3) and purified proteins (Eluate, lanes 4-6).     
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Figure 4-4. Fixation of AtxA complexes with a cysteine-reactive cross-linking agent.  
Cultures of the atxA-null strain UT376 containing pUTE658 (encoding AtxA) or pUTE991 
(encoding AtxA-His) were induced with 40 µM IPTG. Cell lysates or affinity-purified AtxA-His 
were treated with the cross-linking agent BMH. SDS-PAGE (4-15%) and Western blots with 
AtxA-specific antibody were used to detect various forms of AtxA. EV = empty vector, L = cell 
lysate, and AP = affinity-purified.  Molecular weights of the protein standards are listed 
(SeeBlue Plus2, Invitrogen).  
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His was similar to that observed for AtxA and AtxA-His cross-linked in cell lysates 
(Fig. 4-4, lanes 6-8); a doublet band migrated near the 98-kDa molecular weight 
marker. I conclude that the doublet does not result from AtxA linked to another 
protein. Rather, the doublet suggests at least two conformational states of the dimeric 
AtxA complex. 
“BMH-mediated cross-linking of AtxA proteins allowed me to test for region(s) 
at the interface of AtxA multimers. I created strains harboring distinct atxA CysSer 
alleles (Fig. 4-5A). Mutant AtxA proteins were expressed in the atxA-null background 
and cell lysates were reacted with BMH. The presence of the dimer band in lysates 
containing mutated AtxA (Fig. 4-5B) indicates that these proteins are capable of 
multimerization and are cross-linked with BMH. The lysate containing AtxA C402S 
differed significantly from lysates containing other AtxA mutants. The AtxA C402S 
sample contained a relatively low level of cross-linked protein and a high level of the 
apparent monomer. This result suggests that C402 is the major site of BMH 
crosslinking, but some other Cys residue(s) can participate in cross-linking. 
“To determine if the dominant BMH cross-link occurs between C402 of two 
AtxA monomers, AtxA C402S-FLAG was expressed in the parent strain of B. 
anthracis, which also expresses native AtxA from the atxA locus on pXO1. I reasoned 
that if BMH utilizes C402 on both proteins then, after cross-linking, FLAG-reactive 
protein would be detected as a monomer band (55 kDa) and not as a dimer 
containing AtxA C402S-FLAG and AtxA. Following BMH cross-linking, the native AtxA 
plus AtxA C402S-FLAG sample contained a high level of monomer when examined in 
Western blots probed with α-FLAG antibody (Fig. 4-5C, lane 5) similar to the sample 
containing only AtxA C402S (Fig. 4-5B, lane 8). In contrast, samples containing native 
AtxA plus CysSer AtxA mutant proteins (C202S and C370S) or native AtxA plus 
AtxA-FLAG showed high levels of cross-linked protein reacting with α-FLAG antibody  
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Figure 4-5. Determination of the site of BMH cross-linking. (A) The AtxA protein, which 
contains six cysteine residues, has five putative motifs: a winged helix-turn-helix (WH), a 
Mga-like helix-turn-helix (HTH), two phosphotransferase regulation domains (PRD1 and 
PRD2), and an Enzyme IIB-like motif (EIIB). (B) Following induction with 30 µM IPTG, cells 
from cultures of atxA-null strains (UT376) containing pUTE658-derived atxA point mutants 
were lysed and treated with BMH. SDS-PAGE (4-15%) and Western blots with AtxA-specific 
antibody were used to detect various forms of AtxA. (C) A similar experiment was performed 
using derivatives of the parent strain (UT375) expressing atxA from its native locus and 
pUTE992-derived FLAG-tagged versions of AtxA or the AtxA point mutants. Westerns were 
probed with α-FLAG and α-AtxA antibodies. EV = empty vector. Molecular weights of the 
protein standards are as indicated (SeeBlue Plus2, Invitrogen). 
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(Fig. 4-5C, lanes 2-4). Further, when the same samples were probed with α-AtxA 
antibody, dimer bands representing cross-linked AtxA (tagged and native) were 
present in all samples (lanes 6-10). Dimer bands detected in the AtxA C402S-FLAG 
plus AtxA sample probed with α-AtxA (lane 10) likely represent native AtxA because 
dimer bands were not detected when the same sample was probed with α-FLAG 
antibody (lane 5). The relatively low level of cross-linked protein in the sample 
containing only native AtxA (lane 6) and the sample containing native AtxA plus AtxA 
C402S-FLAG (lane 10) reflect low level AtxA expression from the native atxA locus. 
Induction of the tagged proteins (lanes 2-5 and 7-10) resulted in approximately 8.5-
fold more tagged protein compared to native AtxA (Untreated lanes and data not 
shown). These results indicate that the major BMH cross-linked species is formed 
using C402 on two AtxA monomers. 
“To verify that AtxA C402S can form a complex with AtxA despite being 
defective for BMH cross-linking, I performed a co-affinity purification experiment using 
AtxA C402S-FLAG mixed with AtxA-His.  After eluting protein from NTA-Ni resin, AtxA 
C402S-FLAG was present in the sample with AtxA-His, indicating that AtxA C402S 
has normal multimerization properties (Fig. 4-6). Taken together, these data 
demonstrate that BMH utilizes C402 to cross-link two AtxA proteins and suggests that 
the carboxy-terminus of AtxA is involved in oligomerization. 
“Assessment of the carboxy-terminal 91-amino acid sequence of AtxA using 
the Conserved Domains Database (136) and Protein Homology/Analogy Recognition 
Engine (Phyre, (137)), predicted that this region of AtxA is similar to an EIIB motif of 
the PTS, as depicted in Figure 4-5A. EIIB domains typically function enzymatically to 
phosphorylate carbohydrates after the sugars cross the cell membrane via an EIIC 
domain or protein. I performed cross-linking experiments using full length AtxA, AtxA1-
385   (deletion  of the  EIIB-like  motif),  and  AtxA385-475   (only  the  EIIB-like  motif)  to  
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Figure 4-6. AtxA C402S does not have a multimerization defect. Lysates from the 
B. anthracis atxA-null strain UT376 expressing AtxA-His (pUTE991), GFP-FLAG 
(pUTE1013), AtxA-FLAG (pUTE992), or AtxA C402S-FLAG (pUTE992 C402S) were 
subjected to co-affinity purification using NTA-Ni resin. Samples were treated as 
described in Fig. 4-3.     
 
 
  
  68 
determine if the EIIB-like region of AtxA is involved in AtxA oligomerization. Cell 
lysates containing full-length and truncated FLAG-tagged proteins synthesized in 
parent and atxA-null backgrounds were subjected to BMH cross-linking. Bands 
corresponding to 56-kD, 40-kD, and 11-kD monomers of AtxA-FLAG, AtxA1-385-FLAG 
and AtxA385-475-FLAG, respectively, were observed in untreated lysates probed with α-
FLAG antibody (Fig. 4-7 lanes 2-4 and 6-8). The BMH-treated samples displayed the 
typical dimer bands (100 kDa) for AtxA-FLAG (lanes 10 and 14).  The migration of 
AtxA1-385-FLAG was not altered after cross-linking; only a 40-kDa band was present 
(lanes 11 and 15). This result is consistent with the requirement of C402 for cross-
linking. The several FLAG-reactive bands present in lanes 12 and 16 represent 
multiple protein complexes containing AtxA385-475-FLAG and unidentified proteins. The 
large α-FLAG-reactive cross-linking products do not represent AtxA cross-linked to 
AtxA385-475-FLAG because the banding patterns of AtxA385-475-FLAG in the parent (lane 
12) and atxA-null strain (lane 16) were identical. These data indicate that the EIIB-like 
region of AtxA is involved in AtxA oligomerization and suggest that the EIIB-like 
domain in the absence of other regions of the AtxA protein displays less specificity for 
AtxA, interacting with several other proteins in cell lysates. It is notable that the 
truncated AtxA proteins do not exhibit AtxA activity. B. anthracis UT376 mutants 
producing AtxA1-385, AtxA1-385-FLAG, AtxA385-475, or AtxA385-475-FLAG show no 
expression of the Plef-lacZ fusion (data not shown).” (102) 
 
4.2.4 Relationship between CO2/bicarbonate, AtxA multimerization and function 
“AtxA-dependent transcription of lef and other genes is enhanced during 
growth in buffered media in 5% CO2, relative to growth in air (46, 49, 50, 71). To 
address relationships between the CO2/bicarbonate signal, the oligomeric state of 
AtxA, and AtxA function in vivo, I compared AtxA multimerization and activity using  
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Figure 4-7. Multimerization of AtxA385-475. Cell lysates of parent (UT375) and atxA-
null strains (UT376) containing AtxA-FLAG (pUTE992), AtxA1-385-FLAG (pUTE1019-
FLAG), and AtxA385-475-FLAG (pUTE1022-FLAG) induced using 30 - 50 µM IPTG 
were treated with the cross-linking agent BMH.  SDS-PAGE (4-20%) and Western 
blots with FLAG-specific antibody were used to detect various forms of AtxA. EV = 
empty vector.  Molecular weights of the protein standards are listed (SeeBlue Plus2, 
Invitrogen). 
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cells cultured in CA medium with or without CO2/bicarbonate. Growth rates and IPTG-
induced AtxA levels were similar for B. anthracis UT376 (pUTE658) cultures grown 
with or without added CO2/bicarbonate (data not shown). For each culture, AtxA 
function was assessed as β-galactosidase activity resulting from expression of the 
Plef-lacZ reporter gene, and cell lysates were subjected to BMH-mediated cross-
linking to determine the levels of AtxA dimer. A representative experiment is shown in 
Figure 4-8. The AtxA dimer/monomer ratio was approximately 2-fold greater in cells 
cultured with elevated CO2/bicarbonate. The increased dimer level correlated with 
increased AtxA activity. The affect of the CO2/bicarbonate signal on the AtxA 
dimer/monomer ratio and AtxA activity was consistent in multiple experiments. These 
results show that the CO2/bicarbonate signal shifts the dimer/monomer equilibrium of 
AtxA toward the dimeric state and this shift is associated with enhanced protein 
function.”(102) 
4.3 Discussion 
“I have determined that AtxA forms a multimeric protein complex independent 
of other proteins, and that the level of homodimeric AtxA is increased relative to 
monomeric AtxA in cells cultured in conditions conducive for function. My experiments 
employing the BMH cross-linking reagent allow me to discern features of the AtxA 
multimer. BMH is specific for reduced, solvent-accessible cysteines located within 13 
Å. I determined that C402 is the major site of cross-linking between two AtxA proteins, 
suggesting that C402 is likely surface exposed and in proximity to the corresponding 
amino acid in an AtxA dimer. Since BMH cross-linking requires reduced cysteines, the 
C402 residues of associated AtxA proteins do not form a disulfide bond. Moreover, a 
C402S mutant forms multimers that are indistinguishable from those formed by the 
native protein. My data indicate that C402 is located in a region of AtxA that forms 
protein-protein contacts, yet C402 is not required for the protein-protein interactions. 
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Figure 4-8. The CO2/bicarbonate effect on AtxA multimerization and activity. 
UT376 (pUTE658), an atxA-null strain harboring the native atxA gene driven by an 
IPTG-inducible promoter and the Plef-lacZ transcriptional fusion (as a reporter for 
AtxA activity) was cultured in CA in air and in CACO3 in a 5% CO2 atmosphere. Cells 
were collected two hours after induction with IPTG. (A) SDS-PAGE (4-15%) and 
Western blots with AtxA-specific antibody were used to detect various forms of AtxA. 
EV = empty vector (pUTE657), L = cell lysate, U = untreated samples, B = BMH 
treated samples. (B) Intensities of bands corresponding to the AtxA dimer and 
monomer were measured using ImageJ. Dimer/monomer ratios are shown as gray 
bars. β-galactosidase activities, resulting from expression of the Plef-lacZ reporter, 
are shown as black bars.     
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 “The Protein Homology/Analogy Recognition Engine “Phyre” (137) is a 
homology-based, fold-recognition tool that provides three-dimensional structure 
predictions based on sequence similarity to proteins with known structures.  Phyre 
reveals similarity between AtxA385-475, containing C402, and EIIB motifs of PTS 
proteins, leading me to propose a function for the carboxy-terminus of AtxA. As part 
of the PTS, EIIB proteins are the penultimate proteins in the phosphotransfer from 
phosphoenol-pyruvate (PEP) to imported carbohydrates (73).  Within the PTS, 
Enzyme II (EII) complexes, consisting of EIIA, EIIB, and EIIC(D), recognize and 
transport specific carbohydrates.  After EI-dependent phosphorylation of HPr, the 
phosphate is transferred EIIA. EIIA~P phosphorylates EIIB at a conserved cysteine 
residue within the P-loop, a flexible loop between β-strand 1 and α-helix 1 (138).  The 
phosphocysteine of EIIB transfers its phosphate to carbohydrate molecules crossing 
the cell membrane via the EIIC(D) complex.  The carboxy-terminus of AtxA is similar 
to GatB, an E. coli protein that is a member of the glucitol/galacitol family of EIIB 
proteins (139). NMR studies of GatB with its cognate EIIA (GatA) reveal regions of 
GatB – GatA interaction.  It is thought that the GatB-GatA interface, which includes 
the P-loop, is also recognized by the corresponding EIIC protein, GatC (140).   
“Interaction of GatB with two different proteins suggests involvement of EIIB-
like motifs in protein-protein binding. In experiments when AtxA385-475-FLAG is 
induced in an atxA-null strain or the parent strain containing AtxA, I detect four 
prominent α-FLAG-reactive products in cross-linked cell lysates. In contrast, when 
full-length AtxA-FLAG is induced in either strain, cross-linked lysates contain only one 
α-FLAG-reactive product, which corresponds to an AtxA-AtxA dimer.  The presence 
of multiple cross-linked products in the AtxA385-475 sample suggests that the EIIB-like 
motif in the absence of other AtxA domains loses some specificity for protein-protein 
interactions. These data lead me to propose that the EIIB-like motif is involved in the 
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AtxA-AtxA interaction, yet one or more motifs within residues 1-385 of AtxA are 
required to confer specificity to the AtxA-AtxA interaction and to exclude interactions 
of the AtxA EIIB-like domain with other proteins. 
“The presence of an EllB-like motif adjacent to PRDs is not unique to AtxA 
(see Fig. 1-2). EIIB-like domains are found in certain other regulators, including the 
transcriptional activators LicR, MtlR, CelR, ManR and LevR (73, 82, 141).  Yet, unlike 
AtxA, these other regulators also contain EIIA-like motifs and the regulators control a 
small number of genes encoding proteins associated with use of a specific 
carbohydrate or group of carbohydrates.  For example, in Streptococcus mutans CelR 
regulates the production of proteins required for cellobiose catabolism (142), and 
MtlR induces expression of the mtl operon when Bacillus subitilis is in the presence of 
mannitol (84, 143). In contrast, AtxA is a virulence gene regulator that affects 
transcription of multiple genes on the chromosome and virulence plasmids within B. 
anthracis, none of which are known to be associated with catabolism (57).   
“Interestingly, a cysteine residue within the EIIB-like motif in the MtlR protein 
of B. subtilis was recently shown to be phosphorylated (82). MtlR activity decreases 
when P~EIIAMtl phosphorylates MtlR at C419, the conserved cysteine within the P-
loop of the EIIB-like motif. In the Phyre-produced model of the EIIB-like motif of AtxA, 
C402 is located in the P-loop, but the residue is not at the position typically observed 
for the conserved phosphocysteine in EIIB proteins of the PTS or for the EIIB-like 
motif in MtlR and LicT. Moreover, current data do not support phosphorylation of AtxA 
at this site. Phosphorylated C402 would have prevented cross-linking by BMH in my 
experiments. Also, Tsvetanova et al. (59), reported that phosphorylation of AtxA 
occurs only within the PRDs at residues H199 and H379. 32PO4-labelled AtxA was 
immunoprecipitated from B. anthracis cell lysates, but no radio-labelled AtxA was 
evident in a H199A / H379A mutant. 
  74 
“Phosphorylation of AtxA may impact the multimeric state of the protein.  
Phosphorylation can stabilize or disrupt dimerization of the PRD-containing 
antiterminator proteins LicT and BglG (79, 80, 128, 134).   Dimer contacts within the 
PRDs of LicT are confined to α-helices 2, 3, and 5 in each PRD, and the helices are 
arranged in an anti-parallel orientation (135).  Considering reports concerning LicT 
and BglG, it is possible that the AtxA PRDs are involved in multimerization.  The 
Phyre-predicted structure of the PRDs of AtxA positions C202 in α-2 of PRD1, C356 
in α-4 of PRD2, and C370 in α-5 of PRD2, yet in my studies, C202, C356, and C370 
were not required for cross-linking of AtxA proteins by BMH. It is possible that these 
cysteine residues are in regions that function in multimerization.  However, the 
sulfhydryl groups are inaccessible to BMH because they are buried in the interior of 
AtxA, oxidized into a disulfide bond, or are greater than 13 Å from another cysteine.  
More work needs to be performed to determine the protein-protein contacts existing 
throughout the AtxA protein and to assess potential effects of phosphorylation on 
multimerization of AtxA (See Ch. 5). 
“My findings show for the first time a link between AtxA multimerization, 
function and an important signal for virulence gene synthesis by B. anthracis. 
Increased synthesis of PDGA capsule and the anthrax toxin proteins during culture of 
B. anthracis in the presence of elevated CO2/bicarbonate was first reported more than 
sixty years ago. Yet, the mechanism by which this physiologically relevant signal 
affects expression of these critical virulence factors has remained largely unknown. In 
work presented here, I have determined that B. anthracis cultures grown in elevated 
CO2/bicarbonate contain higher levels of the AtxA dimer than cultures grown in air. 
Conditions that enhance dimerization also promote AtxA target gene expression. The 
positive correlation between CO2/bicarbonate level, the presence of AtxA dimers, and 
AtxA activity links the signal to AtxA structure and function.  
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“Many questions remain regarding the mechanism by which CO2/bicarbonate 
affects AtxA function. Genetic and biochemical searches have not revealed any 
cellular factors that might bridge the link between the CO2/bicarbonate signal and the 
AtxA protein. I speculate that AtxA may bind to bicarbonate or CO2 directly. To my 
knowledge, only one bacterial regulatory protein has been shown to require 
bicarbonate to stably interact with target promoter sequences.  RegA, an AraC/XylS-
like regulator found in Citrobacter rodentium, binds to bicarbonate via an amino-
terminal motif (144). According to the model proposed by Yang et al. (145), the 
binding of bicarbonate to RegA facilitates interaction of its carboxy-terminal DNA 
binding motif with target sequences. AtxA does not bear apparent sequence 
homology to RegA, although a binding pocket may not be obvious. Multiple 
bicarbonate-binding proteins, with varying bicarbonate binding sites and diverse 
functions have been reported, including proteins associated with photosynthesis and 
menaquione biosynthesis (146, 147).  Direct association of bicarbonate with AtxA 
multimers is currently under investigation. 
“Finally, my experiments were designed to detect stable protein-protein 
complexes. I do not exclude the possibility of other AtxA-protein interactions. 
Considering that specific DNA-binding activity has not been demonstrated for purified 
AtxA protein, it is possible that an additional protein interacts with AtxA to allow 
specific DNA-binding. Moreover, a specific multimeric and/or phosphorylated form of 
AtxA may be required to observe this activity. Although it has been suggested that 
AtxA phosphorylation occurs via the HPr enzyme of the PTS, the kinase has not been 
identified experimentally. It is likely that the enzyme responsible for phosphorylation 
of AtxA makes transient protein-protein contacts and thus would not be identified by 
the approaches used here.  
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“My working model is that formation of an AtxA homo-dimer is required for 
virulence gene activation. Future studies will focus on potential relationships between 
phosphorylation, multimerization, and function of AtxA.” (102) 
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Chapter V 
The B. anthracis phosphoenolpyruvate:sugar phosphotransferase 
system (PTS) regulates expression, not function, of AtxA, the virulence 
gene regulator. 
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5.1 Introduction 
 The phosphoenolpyruvate: sugar dependent phosphotransferase system (PTS) 
serves as a central processing circuit, allowing bacteria to adapt to changing conditions in 
the local environment (73).  The PTS directs carbon catabolite repression (CCR) and carbon 
catabolite activation (CCA) which affect genes involved in metabolism and bacterial 
pathogenesis (74, 148). Moreover, the PTS phosphorylates proteins as the primary 
mechanism to modify metabolism.   
CCA and CCR and PTS-dependent phosphorylation are intersecting pathways that 
converge with the protein HPr.  In Bacillus subtilis, HPr, the second of the two general 
enzymes in the PTS (EI and HPr), is phosphorylated by two proteins ((74), see Fig. 1-3).  
H15 of HPr (P~His-HPr) is phosphorylated by EI following catalysis of phosphoenolpyruvate 
(PEP) to pyruvate.  To generate P-Ser-HPr, S46 of HPr is phosphorylated by HprK/P in an 
ATP-dependent fashion when cellular levels of fructose-1,6-bisphosphate (FBP) are high (> 5 
mM).  Some carbohydrates promote phosphorylation on H15 and S46 in the same molecule 
of HPr (HPr-P2).  A bacterium’s carbon source dictates the proportion of P~His-HPr, P-Ser-
HPr, and HPr-P2 in the cell (149).  P~His-HPr phosphorylates several different types of 
proteins, whereas P-Ser-HPr specifically interacts with CcpA to induce CCA and CCR.   
P~His-HPr is responsible for phosphorylating EIIA (73), GlpK (150, 151), and PRD-
containing antiterminators and activators (73).  The phosphorylated proteins promote 
catabolism of a specific sugar (EIIA and GlpK) or increase the transcription of genes needed 
for sugar catabolism (PRD-containing proteins).  P~His-HPr phosphorylates two histidines 
within PRD2 of LicT, a B. subtilis antiterminator protein controlling genes involved in the 
metabolism of β-glucosides (77, 152, 153).  Once phosphorylated, LicT homodimerizes and 
prevents transcriptional termination of the lic operon (79). 
P-Ser-HPr forms a heterotetramer with CcpA, the master regulator of CCA and CCR 
within low G+C Gram-positive bacteria (74).  The complex binds to promoter elements (cre 
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sites) to repress (CCR) or activate (CCA) transcription (154).  In B. subtilis, ~10% of the 
genome is regulated via CcpA/P-Ser-HPr (155). Glucose is one of a few carbohydrates that 
increase the intracellular concentration of FBP leading to increased HprK/P phosphorylation 
of HPr (149).  The CcpA regulon includes genes associated with pathogenesis of Listeria 
monocytogenes, Streptococcus pyogenes, and Bacillus anthracis (66, 76, 156).   
  Recent discoveries implicate P~His-HPr and P-Ser-HPr in the regulation of virulence 
in B. anthracis, the causative agent of anthrax disease.  Transcriptional activation of 
virulence genes occurs via AtxA, a PRD-containing protein encoded on the large plasmid 
pXO1 (46, 47).  P~His-HPr of the PTS has been suggested to phosphorylate a histidine 
within the PRDs of AtxA (59, 157).  Moreover, the CcpA/P-Ser-HPr complex indirectly 
promotes transcription of atxA (66).    
P~His-HPr may phosphorylate AtxA on H199 and indirectly provide the phosphate 
needed for another protein to phosphorylate H379.  According to the current model for AtxA 
function, phosphorylation of AtxA at H199 increases AtxA activity whereas at H379 it reduces 
the function of the protein (59).  Using point mutations mimicking the phosphorylated and 
non-phosphorylated states (HD and HA, respectively), Tsvetanova et al. (59) assessed 
the function of AtxA point mutations using a pagA-lacZ reporter fusion in the heterologous 
host B. subtilis.   AtxA H199D had the highest activity though it produced only 1.3 times the 
activity of AtxA, whereas expression of pagA-lacZ via AtxA H199A was reduced sixfold.  
AtxA H379D displayed the lowest function as it induced little or no expression of the reporter 
fusion.  In contrast, AtxA H379A had similar activity as the wild type protein.  To confirm the 
data from the B. subtilis reporter, the authors detected PA protein in culture supernates from 
B. anthracis strains expressing the mutated proteins.  Significantly, in vivo 32P-labeled AtxA 
was immunoprecipitated from B. anthracis cell lysates; however, the bacteria were cultured 
in a medium that does not promote high levels of AtxA activity.  AtxA H199A and AtxA 
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H379A were phosphorylated as well; however, AtxA H199A/H379A, the double mutant, was 
not labeled.  These data indicated that AtxA was phosphorylated at H199 and H379.  
There is some evidence that the PTS represses AtxA function via phosphorylation of 
H199 and/or H379 (59).  A B. subtilis mutant lacking HPr and EI via a deletion in ptsHI 
produces twofold higher AtxA activity than the B. subtilis parent strain.  B. subtilis cultured in 
medium supplemented with glucose was delayed in pagA-lacZ expression.  These data 
supported a model that AtxA is phosphorylated via a mechanism involving P~His-HPr (59, 
157).  In contrast, when B. anthracis, the native host of AtxA, was cultured in medium 
containing glucose, more toxin gene and atxA expression were detected than in medium 
lacking the carbohydrate.  The observation that atxA and toxin gene expression increase in 
glucose-containing medium indicated that atxA was subject to CCA.  The result from B. 
subtilis, the heterologous host, indicated that atxA was repressed in glucose-containing 
medium; however, atxA gene expression was stimulated by glucose in B. anthracis (66). 
The glucose-effect on atxA expression in B. anthracis is mediated by CcpA.  After 
determining that AtxA protein function was unaffected by glucose, Chiang et al. (66) 
demonstrated that a B. anthracis ΔccpA mutant reduced the amount of atxA and toxin gene 
transcripts similar to cultures without glucose.  However, there is not a cre site near the atxA 
promoter and purified CcpA was not able to bind to the atxA promoter; therefore, the 
mechanism of CcpA-dependent regulation of atxA has not been elucidated. It is proposed 
that CcpA and P-Ser-HPr cooperatively activate the atxA promoter in an indirect manner 
(66); however, there is no conclusive link between HPr and atxA transcription.   
Since CcpA/P-Ser-HPr regulates transcription of specific genes and P~His-HPr may 
phosphorylate PRD-containing proteins, I hypothesize that the PTS regulates B. anthracis 
virulence in two ways.  CcpA/P-Ser-HPr may activate transcription of atxA while P~His-HPr 
phosphorylates AtxA.  In work presented in this chapter, I present experiments which provide 
support for HPr function in atxA transcription; however, my data show that the PTS does not 
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affect AtxA protein function.  Because the kinase of AtxA is unknown, I investigated the 
multimeric properties of phosphomimetic versions of AtxA to determine if the mutant proteins 
follow the model of PRD-containing proteins. 
 
5.2 Results 
5.2.1 EI and HPr do not phosphorylate AtxA in vitro. 
 Previously, it was shown that the PRDs within AtxA were phosphorylated in vivo 
potentially via the PTS (59).  As shown with LicT and MtlR (84, 153), PRD-containing 
proteins can be phosphorylated in vitro when combined with EI, HPr, and 32P-PEP.  Given 
the presence of PRDs within AtxA, I hypothesized that HPr phosphorylates AtxA.   
To address this question, I attempted an in vitro phosphotransferase experiment.  
AtxA containing a carboxy-terminal hexa-histidine tag (AtxA-His) was purified from B. 
anthracis to yield highly purified, soluble protein (see Fig. 4-2B).  Expression of hexa-
histidine-tagged versions of HPr and EI was induced via the IPTG-inducible Phs in B. 
anthracis, and the proteins were purified via NTA-Ni affinity chromatography.  EI-His, HPr-
His, and AtxA-His were incubated with 32P-PEP and subjected to SDS-PAGE.  A phosphor-
image of the experiment displayed phosphorylated EI-His and HPr-His (Fig. 5-1A, lanes 1, 4, 
5, and 7).  An unidentified protein was also present in lanes 1, 4, 5, and 7.  I presume that 
the protein was a fragment of EI.  HPr-His and AtxA-His were not phosphorylated when they 
were alone or incubated together (lanes 2, 3, and 6).  Moreover, AtxA-His was not 
phosphorylated by EI-His and HPr-His (lane 7).  All three proteins were detected via 
immunoblot analysis using α-His antibody (Fig. 5-1B).  The lack of AtxA phosphorylation was 
surprising, because HPr has been demonstrated to phosphorylate several PRD-proteins 
during in vitro reactions (82, 84, 153, 158–160).  The results suggest that EI and HPr do not 
transfer phosphate directly to AtxA.   
 
  82 
 
 
 
 
 
 
 
 
 
Figure 5-1.  Phosphotransferase assay does not produce phosphorylated AtxA. Hexa-
His tagged EI, HPr, and AtxA were induced in B. anthracis and purified via nickel-affinity 
purification. A.32P-PEP was mixed with the proteins and incubated at 37° C for 30 min.  
Samples were separated on 10% poly-acrylamide-SDS gels, dried, and exposed to a 
phosphor-imaging screen.  B. The proteins also were subjected to SDS-PAGE and probed 
with α-His antibody.  Proteins present in each lane are indicated by the table.  
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5.2.2 The PTS affects transcription of atxA 
To substantiate the results of the in vitro phosphotransferase assay and further 
investigate the role of EI and HPr on AtxA function, I constructed a markerless mutation of 
ptsHI in B. anthracis.  When a B. subtilis ΔptsHI mutant was tested for AtxA activity, the 
mutant displayed higher expression of an AtxA-dependent target (pagA-lacZ) than the parent 
strain (59).  Given the difference between B. subtilis and B. anthracis in the effect of glucose 
on toxin gene expression, it is necessary to determine in B. anthracis the relationship 
between AtxA and the PTS. 
The genes encoding HPr and EI were deleted from the chromosome of two strains of 
B. anthracis: a parent strain (ANR-1) and an isogenic strain (UT375) that includes lacZ 
integrated at the native lef locus (Plef-lacZ).  Plef-lacZ provides a quantitative reporter of 
AtxA function in vivo.  The lef gene encodes for the Lethal Factor (LF), one of the anthrax 
toxin proteins, and transcription of the gene is highly dependent upon AtxA (46, 49).  The 
ANR-1 ptsHI mutant (UT405) and the UT375 ptsHI mutant (UT408) displayed a slight 
reduction in replication rate in toxin-inducing medium (CACO3) but had no growth defect in 
rich medium (LB or BHI media) (data not shown). 
To assess atxA transcription and AtxA activity, low-copy plasmids carrying 
transcriptional reporters, PatxA-lacZ or Plef-lacZ, were inserted into UT405.  The ptsHI 
mutant displayed little lacZ activity from either promoter fusion when streaked on a CACO3 
plate containing X-gal (Fig. 5-2A).  In contrast, the parent strain containing the reporter 
fusions displayed β-galactosidase activity indicating the atxA and lef promoters were active.  
These data suggest that ptsHI affects atxA transcription.   
The ptsHI mutation was complemented by inducing expression (Phs) of His-tagged 
alleles of ptsH or ptsI or the native version of the ptsHI bicistron.  The UT375-derived ptsHI-
null mutant (UT408) containing the complementation vectors was cultured in toxin-inducing 
conditions.   Induction of HPr and EI began during early exponential phase of growth (2 h,  
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Figure 5-2.  ptsHI mutation affects expression of atxA in B. anthracis. 
  85 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-2.  ptsHI mutation affects expression of atxA in B. anthracis. A markerless 
mutation of ptsHI was constructed in the ANR-1 strain of B. anthracis producing UT405. A.  
Plasmid-borne transcriptional reporters of the promoters for atxA and a toxin gene (PatxA-
lacZ and Plef-lacZ, respectively) were transformed into the mutant and parent strain.  The 
strains were streaked onto CACO3 plates containing X-gal and incubated at 37° C with 5% 
CO2.  
To create UT408, the mutation was made in the ANR-1 derived strain UT375 which 
contains an integrated lacZ gene in the lef locus.  Plasmids containing ptsH (H), ptsI (I), or 
ptsHI (HI) controlled by an IPTG-inducible promoter (Phs) or the empty vector (EV) were 
introduced into UT408 and its parent strain, UT375.  B. The strains were cultured in CACO3 
with added glycerol. After induction of ptsH, ptsI, or ptsHI using 250 µM IPTG (2 h, OD600 = 
0.202 – 0.302), soluble cell lysates were created at the transition to stationary phase (4 h, 
OD600 = 0.93 – 1.43) and subjected to SDS-PAGE and Western blot analysis using α-AtxA 
and α-RNA Polymerase β subunit.  C. The β-galactosidase activity of B. anthracis mutants 
harboring the Plef-lacZ reporter (UT375 and UT408) and IPTG-inducible ptsH, ptsI, or ptsHI 
was determined as described previously (130).  These data are representative of three 
experiments. 
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OD600 = 0.202 – 0.302) and samples for AtxA westerns and β-galactosidase assays were 
collected at the transition to stationary phase (4 h, OD600 = 0.93 – 1.43). Only the dual 
expression of HPr and EI restored AtxA protein levels and Plef-lacZ activity (Fig. 5-2B, lane 
5, and 5-2C).  AtxA was not detected on the Western blot in the ptsHI mutant strain 
containing the empty vector or expressing HPr-His or EI-His alone (lanes 3 and 4).  These 
data support the results from the plate assays (Fig. 5-2A) and indicate that mutation of ptsHI 
abrogates atxA transcription which leads to decreased activation of lef.  It is likely that the 
mechanism by which ptsHI affects atxA involves CcpA, which was shown previously to 
regulate atxA (66). 
 
5.2.3 AtxA function is independent of ptsHI 
It was surprising that mutation of ptsHI leads to decreased amounts of atxA transcript, 
because in most instances, PRD-containing proteins are regulated post-translationally via 
HPr phosphorylation, not by transcriptional control via CcpA/P-Ser-HPr (73, 82).  One 
exception is a LevR-like protein in Lactobacillus casei (161).  LevR, characterized in B. 
subtilis, is a PRD-harboring protein that regulates the fructose-specific PTS (83).  In L. casei, 
the activity of the LevR-like protein is regulated via phosphorylation by P~His-HPr, and 
expression of the LevR-like protein is regulated by CcpA/P-Ser-HPr (161).  To determine if 
the PTS affects AtxA protein function in addition to promoter activity, I investigated if AtxA 
activity was altered in the ΔptsHI mutant. 
The PTS can both positively and negatively regulate PRD-containing proteins (73); 
therefore, it may decrease or increase AtxA activity.  If the PTS induces AtxA function, then 
the protein’s activity may be diminished when the mutant strain is cultured in toxin-inducing 
conditions (CACO3).  On the other hand, if the PTS decreases AtxA activity, AtxA may 
display a hyper-active phenotype in the ptsHI mutant cultured in a medium that does not 
produce optimal levels of toxin (LB-air).   
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To produce AtxA and measure the amount of AtxA activity, I transformed the UT375 
ΔptsHI strain (UT408) with the IPTG-inducible Phs-atxA expression vector (pUTE658).  The 
strain was cultured alongside the parent strain (UT375) and a UT375-derived atxA-null strain 
(UT376) in CACO3 or LB-air.  These three strains contain the Plef-lacZ reporter integrated at 
the lef locus.  After induction with IPTG during early exponential phase, samples were 
collected at the transition to stationary phase for Western blots and Plef-lacZ activity assays.  
AtxA was present in CACO3 cultures of the parent strain containing the empty vector and the 
mutant strains inducing Phs-atxA (Fig. 5-3A, lanes 1, 3, and 5).  All samples containing 
detectable amounts of AtxA also exhibited equivalent β-galactosidase activities (Fig. 5-3C).  
These data indicated that AtxA function was not activated by ptsHI.  When culturing in LB-air, 
AtxA protein was detected only in strains containing Phs-atxA and induced with IPTG (Fig. 5-
3B, lanes 8 and 10).  The activities of AtxA were over 2-logs lower in strains containing AtxA 
than the same strains cultured in CACO3 (Fig. 5-3D, compare to Fig. 5-3B).  There was little 
difference between the Plef-lacZ activities in the ΔatxA – Phs-atxA and ΔptsHI – Phs-atxA 
strains.  These data suggested that EI and HPr and the proteins that are phosphorylated by 
EI and HPr do not negatively impact AtxA protein function.   
When data from the in vitro and in vivo assays are analyzed collectively, I conclude 
that EI and HPr, and by extension, the entire PTS, affect virulence gene regulation via the 
control of atxA gene expression and the system has no control over AtxA protein function.   
 
5.2.4 Effects of phosphomimetic mutations on AtxA multimerization and function 
Although the PTS does not phosphorylate AtxA, data suggest that AtxA is 
phosphorylated in vivo (59).  Using HA and HD point mutations within AtxA, the authors 
conducted experiments suggesting that phosphorylation of H199 promotes AtxA activity and 
H379 phosphorylation decreases AtxA activity.  Alanine substitutions mimic the non-
phosphorylated state of a histidine, while HD mutations are similar to a phosphohistidine. It  
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Figure 5-3.  Expression of AtxA in B. anthracis PTS mutants. UT375-derived ptsHI and 
atxA mutant strains (UT408 and UT376, respectively) containing a plasmid-encoded IPTG-
inducible atxA (Phs-atxA) or an empty vector (EV) were cultured in conditions optimal 
(CACO3, see A. and C.) or suboptimal (LB-air, see B. and D.) for toxin gene expression.  
AtxA production was induced during early exponential phase (2 h) and samples were 
collected for immunoblots or β-galactosidase assays (4 h).  Representative data are shown.  
A. and B.  Soluble cell lysates migrated through 10% poly-acrylamide SDS gels and were 
probed with α-AtxA antibody.  RNA Polymerase β subunit or a cross-reactive band are 
shown as loading controls.  C. and D. The β-galactosidase activity of each strain was 
determined as described previously (130).  
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is unknown if phosphorylation affects the amount of AtxA multimer, which is proposed to be 
needed for AtxA to be active (see Chapter 4).   
To determine the oligomeric state of AtxA phosphomimetic mutant proteins, I created 
AtxA H199 and H379 mutations in the Phs-atxA expression vector (pUTE658) and expressed 
the proteins in UT376, an atxA-null mutant harboring a transcriptional fusion, Plef-lacZ.  
While culturing in toxin inducing medium, cells were induced with IPTG during early 
exponential phase (T2), and samples were collected at the transition to stationary phase (T4) 
to assess the activity and multimeric state of each mutant protein (Fig. 5-4).  As seen 
previously (59), AtxA H199D and AtxA H379A had activity similar to the parent strain in a 
representative experiment,  AtxA H199A had 3-fold less activity, and the activity of AtxA 
H379D is slightly greater than the empty vector control (Fig. 5-4A).   
To detect multimerization of the mutant proteins, I performed co-affinity purification 
(co-AP) and bis(maleimido) hexane (BMH) cross-linking assays.  The co-AP experiment 
determines if a FLAG-tagged protein interacts with an affinity-purified His-tagged protein. The 
Load samples (Fig. 5-4B, lanes 1-6) display the proteins induced in each pool of cell lysates.  
FLAG-tagged proteins which interact with AtxA-His during the NTA-Ni purification were 
detected via α-FLAG immunoblots of the eluate samples (Fig. 5-4B, lanes 7-12, middle 
panel).  AtxA-FLAG stably interacts with AtxA-His as previously demonstrated (Fig. 5-4B lane 
8, and Fig. 4-3).  AtxA H199A-FLAG, AtxA H199D-FLAG, and AtxA H379A-FLAG co-affinity 
purify with AtxA-His.  In contrast, AtxA H379D-FLAG was not visible after elution of the 
proteins from the NTA-Ni resin (Fig. 5-4B, lane 12).   
In the BMH cross-linking experiment, BMH reacts specifically with C402 of AtxA to 
covalently link two AtxA proteins within an AtxA multimer (Fig. 4-5).  Cell lysates were 
created from strains inducing the untagged AtxA mutant proteins. After treatment with BMH, 
the dominant form of AtxA detected via Western blot after SDS-PAGE was the homodimer at 
~100  kDa  (Fig. 5-4C, lane 2).    Bands with  similar mobilities  were  visible in  lanes  3-5,  
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Figure 5-4.  Phosphomimetic mutations affect AtxA activity and multimerization.   
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Figure 5-4.  Phosphomimetic mutations affect AtxA activity and multimerization.  B. 
anthracis atxA-null strains (UT376) containing pUTE658 (encoding AtxA or mutations in 
H199 or H379) were induced with 10-40 µM IPTG while culturing in CACO3 and samples 
were collected for AtxA activity and multimerization assays.  A. Activity of Plef-lacZ was 
determined via β-galactosidase assay as described previously (130). B. Lysates from UT376 
containing AtxA-His (pUTE991), AtxA-FLAG (pUTE992) with H199 or H379 mutations, or 
GFP-FLAG (pUTE1013) induced with 40-50 µM IPTG were subjected to co-affinity 
purification using NTA-Ni resin.  Western blots probed with α-AtxA, α-FLAG, and α-His 
antibodies were performed on soluble cell lysates (Load, lanes 1-6) and purified proteins 
(Eluate, lanes 7-12).  C.  Cultures of UT376 containing pUTE658 (encoding AtxA or 
mutations in H199 or H379) were induced with 40 µM IPTG. Cell lysates were treated with 
the cross-linking agent BMH. SDS-PAGE (4-15%) and Western blots with AtxA-specific 
antibody were used to detect various forms of AtxA. EV = empty vector. Molecular weights of 
the protein standards are listed (SeeBlue Plus2, Invitrogen). 
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indicating that AtxA H199A, AtxA H199D, and AtxA H379A form a normal AtxA multimer.  
Conversely, the major band for AtxA H379D was at ~50 kDa, the monomer size of AtxA.  As 
seen for the co-AP experiment, AtxA H379D does not appear to form a multimer.  These 
data indicate that H379D mutation destabilizes the AtxA multimer.  From these data, I 
deduce that phosphorylation of H379 decreases AtxA activity via decreased affinity for AtxA-
AtxA binding. 
 
5.3 Discussion 
 AtxA, the master regulator of virulence of B. anthracis, may be controlled via two 
mechanisms involving HPr.  Previous reports suggested that CcpA/P-Ser-HPr affects atxA 
transcription and that AtxA is phosphorylated in a P~His-HPr-dependent manner (59, 66, 
157). In the work presented herein, data from biochemical and genetic experiments suggest 
that the PTS influences atxA transcription; however, PTS-mediated phosphorylation of AtxA 
was not detected.  
An in vitro phosphotransferase assay provides evidence of protein phosphorylation 
via EI and HPr.  In the phosphotransfer experiment, EI utilizes 32P-PEP as a substrate to 
phosphorylate HPr at H15.  P~His-HPr donates its phosphate to the PRD-containing protein 
in the reaction.  Phosphotransferase assays have demonstrated phosphorylation of several 
PRD-containing proteins including the B. subtilis proteins SacT (158), LicT (153), LevR (160), 
GlcT (159), and MtlR (82).  I expressed and purified amino-terminal His-tagged EI and HPr 
from B. anthracis which display 74% and 73% identity, respectively, to their B. subtilis 
counterparts. AtxA was not phosphorylated in the assay whether it was incubated with EI or 
HPr alone or with both proteins.   
Since AtxA was not phosphorylated in the experiment, it is necessary to ensure the 
purified proteins (EI, HPr, and AtxA) were functional.  EI is a large protein (570 amino acids, 
62.9 kDa) which contains two functional domains.  The amino terminus contains the site of 
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phosphorylation when the carboxy terminus catalyzes the conversion of PEP to pyruvate; 
therefore, both of the domains must be active if the protein is phosphorylated.  HPr contains 
only 87 amino acids and is 9.2 kDa (73).  P~His-HPr donates its phosphate to many proteins 
including sugar-specific EIIAs (up to 15 in a single cell), glycogen phosphorylase, and PRD-
containing proteins (73).  The same narrow region of HPr is used to interact with EI, EIIAs, or 
glycogen phosphorylase (162, 163).  Thus, like EI, if HPr is phosphorylated it is presumed to 
be functional.  Purified AtxA has been shown to bind DNA (Fig. 3-4) and form multimers in 
solution (Fig. 4-2), thus it is likely that it is folded correctly.  These data suggest that the 
proteins are functional; however, a protein known to be phosphorylated by HPr is needed to 
confirm that HPr is active in the assay.   
ptsHI mutant strains were constructed in B. anthracis to identify if EI and HPr have an 
indirect role in AtxA protein function.  Deleting EI and HPr in B. subtilis has pleiotropic effects 
on carbohydrate utilization and CCR (73, 164, 165).  Loss of EI and HPr leads to a defect in 
PTS-dependent sugar import due to the lack of phosphorylation of the EII complexes which 
transport and phosphorylate a carbohydrate as it transits the cell membrane.  Additionally, 
disruption of ptsH will prevent CcpA/P-Ser-HPr from interacting with its target promoters.  B. 
subtilis ΔptsHI strains have reduced growth rates on several PTS sugars.  In the conditions 
used for my experiments, only a slight delay in replication was detected for the B. anthracis 
ΔptsHI strain.  However, removal of ptsHI resulted in a decreased amount of toxin gene and 
atxA expression and AtxA protein.  Loss of atxA transcript presumably led to the decrease in 
the Plef-lacZ transcriptional reporter.   
HPr and EI may affect atxA transcription via CcpA.  Chiang et al. (66) determined that 
CcpA indirectly increases atxA transcript level.  It is also well-established in B. subtilis that 
CcpA requires P-Ser-HPr in order to bind to target promoters (75). Due to the absence of 
HPr in the ptsHI mutant, CcpA would not be able to bind to target promoters and this would 
lead to misregulation of the atxA promoter.   
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Plasmids harboring IPTG-inducible ptsH, ptsI, and ptsHI were used to complement 
the ptsHI mutation.  Only the vector encoding HPr and EI was capable of increasing AtxA 
protein in the mutant background.  Over-expression of ptsH was not able to complement the 
ΔptsHI mutation.  These data indicate that both EI and HPr are needed for atxA expression.  
Typically when both EI and HPr are needed for a function, it is due to EI-dependent 
phosphorylation of HPr H15.  However, I propose that HPr is interacting with CcpA and the 
requirement of EI is related to the physiological state of the bacterium.   
I reason that EI is needed for atxA expression, because EI increases fructose-1,6-
bisphosphate (FBP) levels leading to phosphorylation of HPr S46 by HprK/P.  FBP is an 
intermediate in glycolysis produced only when the PTS is functioning properly (74).  In the 
ΔptsHI strain, glycolysis may not function properly, thus FBP concentrations may be 
significantly affected.  In B. subtilis FBP concentrations can range between 1.8 mM to 14.1 
mM depending on the carbon source and a ΔptsI strain has 1.8 mM FBP (149).  HprK/P 
phosphorylates HPr in an ATP-dependent manner when there is greater than 5 mM FBP in 
the cell (166, 167).  Low levels of FBP would lead to less HprK/P activity and a lower 
concentration of P-Ser-HPr.  Considering this information, I predict that loss of CcpA-
dependent CCA in the ΔptsHI strain was due to the lack of HprK/P phosphorylation of HPr 
when Phs-ptsH was induced.  If CcpA/P-Ser-HPr regulates atxA, expressing a 
phosphomimetic version of P-Ser-HPr (HPr S46D, (168)) in the ptsHI mutant could bypass 
the requirement of EI and FBP.   
Typically, PRD-harboring proteins are activated by HPr-dependent phosphorylation, 
and their function is decreased upon phosphorylation via EIIA and/or EIIB.  However, in B. 
subtilis ΔptsHI strains, PRD-containing proteins either have no activity (82, 141, 153, 169, 
170) or they are constitutively active (171, 172). The PRD proteins LicR, LicT, MtlR, and 
ManR require phosphorylation by P~His-HPr to be active; therefore in the ptsHI mutant their 
activity is depressed severely.  In contrast, LevR and GlcT display constitutive activity in 
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ptsHI-null strains, because EIIA/B motifs are not able to phosphorylate the proteins to 
repress the activity of the regulator (82, 159).  Given these two scenarios, if AtxA function is 
regulated by the PTS, an effect on AtxA activity should be detected in a B. anthracis ΔptsHI 
mutant. 
Deletion of ptsHI does not affect AtxA protein function when AtxA is induced from an 
IPTG-inducible promoter.  The activity of AtxA after induction in the ΔatxA and ΔptsHI strains 
was compared to the parent strain which contains atxA controlled by its native promoter.  In 
toxin-inducing conditions (CACO3), all three strains contained AtxA and produced similar 
levels of AtxA activity.  In LB-air, which is not conducive for toxin gene expression, AtxA was 
only detected when induced from Phs-atxA in the ΔatxA and ΔptsHI strains.  The activity of 
AtxA in each strain was similar, albeit 100-fold lower than the same strains in CACO3.  If 
regulated by the PTS, AtxA activity should be repressed or constitutive.  These data indicate 
that AtxA function is not regulated by ptsHI.  
Taken collectively, the data support only one function of the PTS in virulence gene 
regulation of B. anthracis.  The phenotype of the ptsHI-null strain indicates that CcpA and 
HPr activate transcription of atxA.  Due to the lack of a phosphorylated product in vitro or an 
effect on AtxA in the ΔptsHI, I conclude that EI and HPr do not play a role in activation or 
repression of AtxA activity.   
It is quite surprising that AtxA was not phosphorylated in the phosphotransferase 
assay and that AtxA protein activity was not affected in the ΔptsHI mutant.  To date, all PRD-
containing proteins tested are phosphorylated via HPr and thus regulated by the PTS.  AtxA, 
which has homology to PRD-containing proteins, would be unique in this sense.  However, 
AtxA contains structural features not found on PRD-containing antiterminators and is missing 
a motif present in PRD-containing activators.  PRD-containing antiterminators, such as LicT 
and GlcT, contain an RNA-binding domain and two PRDs (73).  DNA-binding proteins with 
PRDs, including MtlR and LicR, have a DNA binding region, two PRDs, an EIIB-like motif, 
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and an EIIA-like motif (73, 82).  The motif structure of AtxA is predicted to be similar to MtlR 
and LicR; however, the EIIA-like motif is absent.   
Before my work, the phosphorylation state of only one protein within the AtxA/Mga 
protein family has been investigated.  Using a phosphotransfer assay, the group A 
Streptococcus virulence gene regulator Mga is phosphorylated via EI and HPr (McIver, 
personal communication).  Results obtained using phosphomimetic mutations indicate that 
phosphorylation of H204 and H270 decreases Mga activity, whereas phosphorylation of 
H324 increases the function of the protein.   
 Due to the lack of evidence that AtxA is phosphorylated by the PTS, it must be 
considered that AtxA is not phosphorylated in vivo.  The model proposed by Tsvetanova et 
al. (59) suggests that AtxA is phosphorylated at H199 and H379.  The data which support 
AtxA phosphorylation include 32P-labeled products that are immunoprecipitated by α-AtxA 
antibody and the activities of point mutations that mimic phosphorylation or 
dephosphorylation of AtxA (59).  After several attempts, I have been unable to 
immunoprecipitate 32P-labeled AtxA from cells cultured with 32P-phosphate.  I have repeated 
the experiments with the AtxA point mutants and included multimerization assays to gain 
insight into the structural changes conferred by the point mutations. 
 Phosphomimetic mutations should simulate the ionic charge and size of the 
phosphorylated amino acid.  NMR studies comparing P-Ser-HPr and HPr S46D show that 
the proteins have virtually identical structures (173).  HPr H15D and HPr H15E have similar 
affinities as P~His-HPr for HprK/P (174).  Exchanging a phosphohistidine for an aspartic acid 
is the standard mutation used in research of PRD-containing proteins (85, 135, 159).  Both 
aspartic acid residues and phosphohistidines are negatively charged, whereas the histidine 
side chain is positive when the pH is below 6.0.  The carboxyl group in the aspartic acid side 
change also mimics the P-O bond in the phosphate moiety.  These studies suggest that an 
aspartic acid is an appropriate mimic of a phosphorylated amino acid.   
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Using an aspartic acid residue to mimic phosphorylation of AtxA H379, I determined 
that the mutation causes a change in the multimeric properties and activity of AtxA.  AtxA 
H199A, AtxA H199D, and AtxA H379A formed oligomers similar to the native protein.  AtxA 
H379D did not interact with AtxA-His during a co-AP experiment, and it was not susceptible 
to BMH cross-linking.  If it is assumed that AtxA H199D and AtxA H379D represent 
phosphorylated histidines, then these data are in agreement with the model for LicT 
dimerization.  LicT forms a dimer when sites of positive regulation are phosphorylated.  The 
dimer form of LicT is destabilized when phosphorylated at histidines that lower protein 
activity (78–80).   
Although the AtxA H379D mutation supports the model of PRD-containing proteins, 
future experiments should be conducted to determine if the size or charge of the amino acid 
R group is causing the multimerization defect.  Asparagine, glutamic acid, glutamine, serine 
and lysine could be tested instead of aspartic acid.  Glutamic acid has a negative similar to 
aspartic acid and serine contains a polar side chain.  Asparagine and glutamine residues 
contain similar shaped side chains as aspartic acid, except without the charge.  Lastly, a 
lysine would retain the positive charge but increase the size of the histidine side chain.  If 
AtxA H379E and AtxA H379S are the only point mutants to display phenotypes similar to 
AtxA H379D, then the results would suggest that the mutations are mimicking a 
phosphohistidine at position 379.  The data would also support the model that AtxA is 
phosphorylated. 
In summary, AtxA protein function is not regulated via the PTS; however the 
transcription rate of atxA is affected, presumably via CcpA/P-Ser-HPr.  Point mutations at the 
predicted phosphorylation sites lead to the expected phenotypes when considering the 
model of PRD-protein function.  Future experiments will investigate if AtxA is phosphorylated 
independent of the PTS. 
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Chapter VI:  Discussion 
Discussion  
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6.1 Significant findings regarding the structure and function of AtxA 
 AtxA is a critical virulence gene regulator of B. anthracis.  A B. anthracis atxA–null 
mutant is highly attenuated in murine models for anthrax (49, 106).  The level and activity of 
AtxA dictate levels of virulence gene transcription within cells. Steady state levels of AtxA 
protein are impacted by transcriptional regulation of the atxA gene and protein stability.  
Regulation of AtxA activity takes place via post-translational modification and structural 
changes.  Many details are known regarding regulation of the atxA promoter and the effect of 
an atxA-null strain on virulence gene expression (46–48).  However, before the results 
conveyed in this dissertation, researchers knew little about the molecular mechanism of AtxA 
function.   
My research has advanced the study of AtxA significantly.  Chapter 3 describes my 
work to characterize the activity of AtxA when induced by a heterologous promoter, to 
analyze the two large domains within the AtxA protein, and to determine the affinity of AtxA 
for DNA.  In Chapter 4, I describe experiments demonstrating that AtxA forms a 
homomultimeric structure, possibly a dimer.  Formation of the multimer is dependent upon 
the EIIB-like motif, enhanced by CO2/bicarbonate, and may be needed for optimal AtxA 
function.  Data presented in Chapter 5 support previous evidence suggesting that CcpA/P-
Ser-HPr regulates atxA transcription.  On the other hand, my data challenged a previously 
proposed model in which the PTS phosphorylates AtxA.  I show that AtxA function is not 
affected by EI or HPr.  Finally, my studies on AtxA demonstrate that AtxA H379D is deficient 
in multimerization while other H199 and H379 point mutations are able to form oligomers.   
Overall, my data support the following model of AtxA function. Oligomers of AtxA 
associate with specific promoter elements.  AtxA activity is increased in response to the host-
related signal CO2/bicarbonate because this signal enhances AtxA multimerization.  In 
contrast, AtxA activity is decreased by phosphorylation at H379 because multimerization is 
inhibited.  Figure 6-1 and the following section detail a comprehensive model of atxA-
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mediated virulence gene activation based upon previous data and new information 
generated during my thesis work.  
 
6.2 A comprehensive model of B. anthracis virulence gene regulation 
 Steady state levels of functional AtxA are affected by transcriptional regulation of the 
atxA gene, post-translational covalent modification, and finally AtxA oligomerization. Trans-
acting factors affect the activity of the atxA promoter via activation or repression of 
transcription.  Moreover, the stability of the message is impacted by elements encoded within 
the atxA locus.  One global regulator has been shown to affect AtxA protein level indirectly.  
Finally, post-translational modification and ligand-binding may alter the functional state of the 
protein. 
Multiple proteins and signals affect atxA transcription (Fig. 6-1A).  Positive regulators 
include CcpA/P-Ser-HPr and physiological temperature (37° C) (64, 66). AbrB, genes 
involved in cytochrome c biogenesis, and an unidentified repressor protein negatively impact 
atxA transcription (65, 67, 68, 106).  These regulators impact atxA transcription at the σA-
dependent P1 promoter and not at the secondary promoter (P2) (49, 63, 106).  Additionally, 
an extended 3’ end of the transcript is required for stability (175).  
AtxA protein stability is controlled by the pleiotropic regulator CodY in an indirect 
manner (Fig. 6-1B).  A ΔcodY strain of B. anthracis contains normal levels of atxA 
transcription and translation; however the AtxA protein was not detected on Western blots of 
whole cell lysates (62).  The authors of the study suggest that either CodY represses an 
unidentified protease that degrades AtxA or CodY activates an AtxA-binding protein and/or a 
chaperone that promotes AtxA stability.   
Once the atxA gene is transcribed and the protein is stable, AtxA must form the 
proper structure via protein modification and ligand binding (Fig. 6-1C).  The EIIB-like motif  
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Figure 6-1. A comprehensive model of atxA-dependent virulence gene regulation. 
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Figure 6-1. A comprehensive model of atxA-dependent virulence gene regulation. The 
schematic represents three layers of control governing A. atxA transcription, B. AtxA stability, 
and C. AtxA protein activity.  Also presented are the major outcomes of D. AtxA function.  
See text an explanation of the model.  Straight arrows indicate direct regulation, whereas 
dashed arrows suggest indirect or unknown routes of regulation.  A. Upstream of the atxA 
gene are sequences which are bound by repressors (red lines) or an activator (blue line) of 
transcription.  Transcriptional regulation occurs at the primary promoter (P1), not the 
promoter located further upstream (P2).  Downstream of the gene is an extended 3’ 
untranslated region and a stem-loop (Ω).  B. The cartoon depicts five motifs within AtxA: 
winged-helix-turn-helix (WH), Mga-like helix-turn-helix (HTH), two PTS regulation domains 
(PRD1 and PRD2), and an Enzyme IIB-like motif (EIIB-like).   C. A structural model of an 
AtxA homodimer is shown (one subunit is red and the other is blue).   
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facilitates formation of a homomultimeric structure and the amount of multimer correlates 
with AtxA activity.  These results suggest that the multimeric form of AtxA is needed for the 
protein to be active.  The mechanisms that induce or inhibit oligomerization are unknown; 
however, phosphorylation of H379 may inhibit the multimer structure while CO2/bicarbonate 
may promote AtxA oligomer formation. 
Once all three of these regulatory steps are overcome, B. anthracis virulence traits 
are expressed (Fig. 6-1D).  The anthrax toxin genes may be controlled directly by AtxA (46, 
47), whereas AtxA activates PDGA capsule biosynthesis indirectly (Bourgogne 2003).  AtxA 
regulates several genes within the B. anthracis genome and indirectly inhibits sporulation 
(57, 176).    
For the remainder of my discussion, I will highlight several aspects of this model of 
AtxA regulation. 
 
6.3 atxA control by CcpA/P-Ser-HPr and CodY provides a link between metabolism and 
B. anthracis virulence 
Work presented in Chapter 5 provides support for roles of CcpA and HPr in the 
regulation of the atxA gene.  B. anthracis ΔccpA and ΔptsHI mutants contain a low steady 
state level of atxA transcript compared to the parent strain (66).  In a separate study, CodY 
was shown to mediate AtxA protein stability (62).  B. anthracis mutants devoid of codY 
exhibit a decrease in AtxA protein level. CcpA/P-Ser-HPr and CodY act indirectly on atxA to 
regulate virulence presumably through different mechanisms.  Intriguingly, both CcpA/P-Ser-
HPr and CodY activity are influenced by the metabolic state of the bacterium.  Therefore, I 
postulate that the mammalian host provides metabolic signals that prompt B. anthracis to 
induce transcription of atxA and stabilize the AtxA protein.    
 When the local concentration of glucose and other quickly metabolized 
carbohydrates is high, CcpA/P-Ser-HPr represses and activates genes.  Studies in B. subtilis 
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have shown that phosphorylation of HPr S46 is required for the protein to form a heterodimer 
with CcpA (73).  HprK/P is responsible for phosphorylating HPr S46 in an ATP-dependent 
manner when fructose-1,6-bisphosphate (FBP) concentrations are high. ATP and FBP are 
abundant in cells growing on carbohydrates the bacteria can import and metabolize quickly, 
such as glucose.   
In B. subtilis, metabolism of glucose increases the cellular concentration of GTP, 
which is an activating ligand of the regulator CodY.   Branched-chain amino acids (BCAA; 
leucine, valine, and isoleucine) also increase activity of CodY.  GTP levels are an indicator of 
the energetic state of the cell while BCAA represent the abundance of nutrients (proteins) in 
the environment.  Either small molecule is able to induce DNA-binding; however there is an 
additive effect when both interact with CodY (61). 
Glucose and BCAA are readily available in the cytoplasm of host cells (177).  Glucose 
is the preferred carbon source for most host cells, and the normal concentration in plasma is 
1 mg ml-1 (178).  BCAA are available in tissue as proteins are broken down due to starvation 
(179) or proteolytic enzymes, including InhA1 and NprB which are secreted by B. anthracis 
(72, 105).   
Signals and conditions associated with replication of B. anthracis in mammalian 
tissue are simulated by toxin-inducing culture medium.  When cultured in CACO3 broth 
incubated at 37° C with 5% atmospheric CO2, B. anthracis produces high levels of anthrax 
toxin compared to other culture media and atmospheric conditions (Fig. 4-8 and 5-3, (47)).  
CACO3 is a semi-defined medium that contains acid hydrolyzed casein (casamino acids) and 
glucose among other nutrients (99).  Casamino acids contain a mixture of all amino acids, 
including the BCAA.  Since glucose and BCAA promote the activity of CcpA/P-Ser-HPr and 
CodY, respectively, I propose that the major signals influencing the amount of AtxA protein in 
CACO3 are glucose and BCAA.   
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CcpA/P-Ser-HPr and CodY are involved in the production and stability of AtxA.  Since 
these factors are active in the presence of glucose and BCAAs found in the mammalian host, 
these data show a link between virulence gene activation and the metabolic state of the cell.   
 
6.4 Regulation of AtxA protein function via multimerization 
Host-related signals are needed also to promote AtxA protein function.  
CO2/bicarbonate and phosphorylation may regulate AtxA activity separately.  It would be 
interesting to study the interplay between CO2/bicarbonate and phosphorylation with respect 
to AtxA activity and multimerization.  I propose that CO2/bicarbonate locks AtxA into an 
active, multimeric state by facilitating rearrangement of the WH and HTH motifs.  Without 
CO2/bicarbonate, AtxA may still multimerize, but the DNA-binding activity could be reduced.  
Phosphorylation of H199 may initiate formation of the oligomer via ionic interactions between 
the phosphohistidine and a basic amino acid.  On the other hand, phosphorylation at H379 
may deactivate the protein by prohibiting multimerization.  This model for AtxA 
multimerization is similar to the Domain Swing/Lock Mechanism of LicT (79).  In this model, 
AtxA transitions between three functional states: a monomer, an unstable multimer, and a 
stable, highly active multimer.  
The first prediction of the AtxA multimerization model proposes that AtxA has a 
monomeric form and that the AtxA monomer does not activate target promoters.  
Experimental evidence suggests that phosphorylation of H379 prevents proper multimer 
formation.  AtxA H379D did not interact with AtxA-His in a co-AP experiment and it was not 
susceptible to BMH cross-linking (Fig. 5-4).  These data suggest that phosphorylation of 
H379 converts AtxA into a monomer; however, an alternative explanation is that H379 
phosphorylation promotes formation of an unstructured aggregate.   
The AtxA multimerization model suggests that an unstable oligomeric state for AtxA 
serves as a transition point between monomeric and highly stable multimeric states.  This 
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stage would occur in the absence of any post-translational modification or CO2/bicarbonate 
binding to AtxA.  To replicate the non-phosphorylated state of AtxA, I could express AtxA 
H199A and AtxA H379A.  Characterization of the multimeric properties of AtxA H199A and 
AtxA H379A could provide support for a transient stage of multimerization.  AtxA H199A and 
AtxA H379A are capable of forming normal AtxA multimers (Fig. 5-4).  This indicates that 
multimer formation is not dependent on phosphorylation of H199 or H379.  Culturing B. 
anthracis in CA medium in air and the absence of added CO2/bicarbonate would simulate the 
ligand-free state of AtxA.  In this growth condition, AtxA multimer formation and toxin gene 
expression are reduced to 50% of the levels observed in the same conditions but with added 
CO2/bicarbonate (Fig. 4-8).  Since the AtxA multimer was able to form in normal atmospheric 
conditions, AtxA may form a weak oligomer in the absence of CO2/bicarbonate or the small 
molecules may affect AtxA indirectly.   
The final form of AtxA suggested by the AtxA multimerization model is a stable, highly 
active dimer. Ligand-binding and phosphorylation of H199 are the likely modifications needed 
to lock the AtxA multimer into its active conformation.  The relatively low level of toxin gene 
transcription in strains containing AtxA H199A supports the requirement of H199 
phosphorylation for oligomerization.  Although the H199A protein displays normal multimers, 
it produces less than 33% of the activity of native AtxA (Fig. 5-4).  Disruption of 
phosphorylation at H199 may weaken the AtxA multimer resulting in loss of AtxA activity.   
I proposed in section 4.3 that CO2/bicarbonate may bind to AtxA.  At the 2011 
International Conference on Gram-Positive Microorganisms, data were presented suggesting 
that N453 of AtxA was involved in binding bicarbonate and had an impact on AtxA solubility 
(Fouet, personal communication).  The carboxy terminus of AtxA (amino acids 438-469) 
bears weak similarity to the first 32 amino acids of RegA, and within that region, AtxA N453 
aligns with RegA N16 suggesting the residues perform similar functions.  RegA, an 
AraC/XylS-type bicarbonate-binding transcription factor of Citrobacter rodentium, interacts 
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with bicarbonate via an amino-terminal motif (144, 145).  Mutation of RegA N16 to an alanine 
results in constitutive activation of RegA-dependent promoters presumably by mimicking the 
structural changes induced by bicarbonate.  The model of RegA activity proposes that two 
proteins form a dimer via their amino-termini when bicarbonate is present.  Activity of AtxA 
N453A in normal air was similar to AtxA cultured in elevated CO2/bicarbonate.  If AtxA 
functions similarly to RegA with respect to bicarbonate binding and multimerization, then 
bicarbonate-binding would lock AtxA proteins together in a multimeric structure.  Without 
bicarbonate, AtxA oligomers could form, but they would not be stable.   
Applying the Domain Swing/Lock Mechanism to AtxA, I propose that phosphorylation 
and bicarbonate affect AtxA function by altering its multimeric structure.  Monomers of AtxA 
are prohibited from forming oligomers when H379 is phosphorylated.  When bicarbonate 
concentrations are low and the protein is not phosphorylated, AtxA is in a transitional form 
capable of forming weak protein-protein interactions.  The AtxA multimer is locked in a highly 
active state when H199 is phosphorylated and bicarbonate interacts with N453.   
Several experiments may be performed to test the model of AtxA homodimer 
formation.  If the energy transfer between two different AtxA-chromophore fusions can be 
detected in vivo, Förster resonance energy transfer (FRET) experiments could detect 
formation of AtxA multimers.  To observe CO2/bicarbonate enhancement of multimerization, 
FRET measurements may be collected using cells cultured in the presence or absence of 
elevated atmospheric CO2 and dissolved bicarbonate.  I would expect to see greater energy 
transfer when CO2 and bicarbonate are present.  Additional FRET experiments utilizing 
various culture media (LB and CA) or point mutations within one or both AtxA fusions may 
provide additional support for the role of AtxA phosphorylation on the stability of AtxA 
oligomers.   Point mutants of AtxA could also be tested in vitro by performing size exclusion 
chromatography, analytical ultracentrifugation, or surface plasmon resonance.   
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Extensive analysis of an AtxA-bicarbonate interaction has not been done.  It may be 
possible to detect 14C-labeled bicarbonate bound to AtxA.  One method would be to affinity-
purify AtxA-His expressed in cells cultured in the presence of 14C-bicarbonate.  If samples 
containing AtxA had a higher radioactive signal than control samples (no 14C-bicarbonate and 
samples without AtxA), the results would indicate that bicarbonate is a ligand of AtxA. A 
similar experiment can be performed in vitro using purified AtxA-His.  Adding unlabeled 
bicarbonate to purified AtxA-His when performing in vitro multimerization assays or DNA 
binding experiments could enhance the activity of AtxA.  If AtxA binds bicarbonate and the 
binding is lost when AtxA N453A is tested, then N453 of AtxA may function similar to RegA 
N16 and interact with bicarbonate. 
 
6.5 Specific DNA binding by AtxA 
 The proposed Domain Swing/Lock Mechanism of AtxA multimerization describes the 
various quaternary structures that may exist for AtxA.  Each structure either promotes or 
prohibits AtxA function in vivo.  As suggested above, the role of AtxA is to bind to target 
promoters to enhance transcription of the genes.  Work presented in Chapter 3 demonstrates 
that AtxA can bind to DNA promoters; however, AtxA interacted with the sequences non-
specifically.  This portion of the discussion will address the reasons why AtxA bound non-
specifically to DNA and propose future methodologies to attempt when studying AtxA-DNA 
interactions. 
 Filter binding assays were used to assess the interaction between AtxA and promoter 
sequences.  The experiment detects DNA when it has complexed with a protein and 
subsequently binds to a membrane.  In effect, the protein precipitates onto the membrane, 
and DNA is captured during the precipitation.  The protein-DNA affinity is determined using 
target promoters, whereas other DNA sequences are used to control for non-specific protein-
DNA interaction.   
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The filter binding assay has been used to study many proteins and is a valid 
technique; however, it may not be the best method to study AtxA-DNA interactions.  
Precipitation of AtxA, a highly positively charged protein, onto the membrane could indicate 
falsely that the protein is binding to DNA sequences in the assay.  In addition, the interaction 
of the DNA and protein does not need to be very strong.  The method does not require any 
wash steps and there is little opportunity for DNA and protein to dissociate if they are non-
specifically interacting. 
During in vitro analyses, AtxA may be able to bind DNA independent of its multimeric 
state.  Recently, Hondorp et al. described how Mga forms a multimer in solution and that an 
EIIB-like motif is needed for the protein-protein interaction (180).  Interestingly, the authors 
tested the DNA-binding activity of a derivative of Mga lacking the EIIB-like motif.  Although 
the truncated protein was a monomer in solution and had no detectable activity in vivo, it 
bound to DNA with only a slightly weaker affinity (less than 2-fold change) compared to the 
full-length protein.  These data suggest that Mga, and by extension AtxA, may bind to DNA in 
these in vitro assays as a monomer, whereas a dimeric protein is needed in the cell to bind 
DNA and activate transcription. 
There is some precedence for in vitro DNA binding occurring in the absence of the 
appropriate multimeric state.  For example, PhoP, a response regulator involved in Mg2+ 
homeostasis in Salmonella typhimurium, typically binds DNA as a dimer after it is 
phosphorylated (181).  However, when present in high concentrations, unphosphorylated 
PhoP binds DNA as a monomer and then recruits the second monomer to the binding site.  
The affinity of the first monomer to DNA is ~17-fold higher than the affinity of the second 
monomer to the binding site.  These studies were conducted using biophysical methods 
including isothermal titration calorimetry, fluorescence titration measurements, analytical 
ultracentrifugation, and surface plasmon resonance.  It would be interesting to see if similar 
results would be seen using a filter binding assay.  I suggest that the binding affinity of the 
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second monomer of PhoP would be masked by the affinity of the first protein.  Once one 
protein binds to the DNA probe, the probe will stay on the membrane regardless if the 
second monomer is present or not.  If AtxA follows a similar mode of DNA binding where one 
subunit interacts with DNA with a higher affinity than the second subunit, then I would be 
detecting only the interaction of the first subunit.      
For dimeric DNA binding proteins, interaction of the second monomer provides 
specificity and optimal affinity of the protein to its cognate DNA (182).  In several eukaryotic 
systems, DNA-binding proteins within the same family have similar recognition sites.  The 
transcription factors achieve specificity by recognizing a predetermined length between the 
binding sites.  In vitro several proteins can bind to half sites as a monomer, and full binding 
by a dimer only occurs when the spacer between the sites is the correct size.  AtxA may be 
similar in this regard.  AtxA may bind to a pair or series of specific nucleotide sequences or 
structural elements.  If only one of the sites is present on the non-specific probe used in the 
filter binding assay, then AtxA will be able to form a complex and an interaction will be 
detected.   
 In addition to the methods mentioned above in the study of PhoP, Electrophoretic 
mobility shift assays (EMSAs), fluorescence polarization, and DNA foot-printing analyses 
may provide additional information regarding the mechanism and affinity of AtxA to DNA.  
EMSAs allow the protein-DNA complex to be visualized and if more than one form of the 
complex is present, they will be detected.  EMSAs may be problematic due to the high pI of 
AtxA (pI = 9.3).  At a neutral pH, AtxA is highly positively charged and migrates toward the 
cathode rather than the anode like the DNA.  However, the poly-acrylamide concentration of 
the gel and pH of the buffer may be optimized to permit analysis of AtxA via this technique.  
Fluorescence polarization assays allow for protein-DNA interactions to be viewed in real-time 
as they occur in solution.  The assay would not distinguish between a monomer of AtxA and 
a multimer of AtxA; however, it would remove the precipitation step needed for a filter binding 
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assay.  Lastly, foot-printing experiments could provide sequence-specific information 
regarding the AtxA-DNA interaction.  The size of the region protected in the experiment could 
indicate the number of AtxA molecules interacting with the DNA element. 
 The experimental methodology may not be the cause of the non-specific binding of 
AtxA.  It is possible that AtxA is not in the proper form.  The dimer form of AtxA may not be 
the dominant species of the protein in solution.  Post-translational modification and ligand-
binding may confer structural changes within the protein that allow it to specifically interact 
with DNA.  Point mutations of AtxA could mimic the structural changes needed for DNA-
binding.   
    
6.6 A structural model of AtxA 
 Early attempts to crystallize AtxA or determine the solution structure via NMR 
spectroscopy were not successful.  Nevertheless, obtaining the structure of AtxA remains a 
worthwhile pursuit.  Until a crystal or NMR structure is determined, modeling AtxA against 
known structures can be informative and guide future experiments.  Fortunately, the structure 
of an AtxA/Mga family member has been solved. 
The 2.31 Å-resolution crystal structure of the Mga-like protein from Enterococcus 
faecalis was determined recently (PDB file = 3SQN, (88)).  The protein is encoded by the 
gene EF_3013 and annotated as a “conserved domain protein.”  No functional information 
about this protein or gene is known.  The structural motifs of the Mga-like protein match 
those predicted to be in the AtxA/Mga family.  Two HTH, two PRDs, and an EIIB-like motif 
are present producing a structure that is 56% alpha helical and 9% beta sheet.  The protein 
crystallized as a dimer in which the EIIB-like motif of one subunit interacts with the PRDs and 
HTH motifs of the other subunit (Fig. 1-4).  In total, 83 residues are involved in the dimer 
interface with an area of 3182.8 Å2 according to the “Protein interfaces, surfaces, and 
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assemblies” software (PISA, (183)).  It is not known if the structure represents an active state 
of the protein or if the protein forms a homodimer in vivo.     
I used the protein homology/analogy recognition engine (Phyre2, (137)) and the 
Swiss-pdb viewer (184) to construct a structural model of an AtxA homodimer using the Mga-
like protein as a template (Fig. 6-2 and 6-3A).  The Mga-like protein has 19% identity and 
39% similarity (total conservation = 58%) to AtxA.  The model contains residues 89-474 of 
AtxA which encompass the Mga-HTH, PRDs, and the EIIB-like motif.  The WH motif is not 
present in the structure generated by Phyre2.  I have used the structural model to make 
predictions about the functions of AtxA motifs as well as locations of specific residues. 
Viewing the overall motif organization, I can make two observations.  First, the EIIB-
like motif is at the center of the homodimer (Fig. 6-2).  As is true for the structure of the Mga-
like protein, the EIIB-like motif from one chain reaches into a pocket created by the PRDs 
and EIIB-like motif of the second subunit.  If the protein lacked the EIIB-like motif, all contact 
between the subunits would be lost.  In addition, the EIIB-like motifs from each monomer 
form few contacts with each other; therefore, EIIB-like motifs may not interact if expressed 
independently.  My data suggesting that the EIIB-like motif is necessary, but not sufficient, for 
dimerization fit this model.  The second observation is that HTH motifs from both chains are 
on the same face of the dimer, and the motifs are extended from the remainder of the 
protein.  Typically, the HTH motifs of dimeric DNA-binding proteins are located on the same 
side of the complex (126).  In addition, the first residues of the recognition helix of each 
subunit are separated by approximately 98 Å.  Since one turn of DNA is 34 Å and 
encompasses ten nucleotides, the distance between the HTH motifs suggests that AtxA 
binding sites may be separated by greater than 30 bp.  The location of the motifs would allow 
AtxA to bind DNA. 
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Figure 6-2. A structural model of the AtxA homodimer. A stereo image of a structural 
model of AtxA was created using Phrye2 based on the the X-ray crystal structure of the Mga-
like protein from E. faecalis (PDB = 3SQN, chain B).  The motifs of one subunit are colored:  
HTH is red, PRD1 is yellow, PRD2 is cyan, and EIIB-like motif is blue.  The WH motif was not 
modeled.  The second subunit is grey.   
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After viewing the locations of several key residues, I can provide additional analysis 
of their roles in AtxA function and their use in my experiments.  In section 4.2.3, I described 
experiments using CS mutations of AtxA to determine the cysteine required for BMH to 
cross-link two AtxA proteins.  After fixing cell lysates with BMH, AtxA C402S was present 
only as a monomer, whereas the other CS mutations, including AtxA C161S and AtxA 
C202S, were dimers.  When native AtxA and AtxA C402S-FLAG were co-expressed in B. 
anthracis, AtxA C402S-FLAG remained as a monomer indicating that it was not able to 
cross-link with AtxA.  These data suggested that C402 cross-linked to the corresponding 
C402 of the second subunit (C402’).  The data clearly indicate that C402 participates in the 
BMH cross-linking; however, the binding partner of C402 could not be C402’ if the structural 
model is accurate.  C402 is located on the opposite side of the dimer interface from C402’ 
(Fig. 6-3B).  Using the Swiss-pdb viewer software, the residues are over 46 Å from one 
another, which is much greater than the size of the spacer arm of BMH (13 Å).  When 
locating the other cysteines in the AtxA model, I detected a region that contained C161, 
C202, and C402’ within 12 Å of each other (Fig. 6-3C).  Theoretically, C402’ could cross-link 
to C161 or C202 with equal affinity.  However, intermolecular cross-linking of C402’ to C161 
or C202 may compete with intramolecular BMH bonds between C161 and C202.  BMH-
mediated cross-linking of C161-C202 of AtxA C402S-FLAG may explain why the mutant 
protein was not fixed to native AtxA (Fig. 4-5C).  To address if C402’ cross-links to C161 or 
C202, I could determine if AtxA C161S/C202S is susceptible to BMH cross-linking.  
In addition to C402 being important for the BMH cross-linking experiment, it may have 
a significant role in vivo.  As described in section 4.3, C402 resides within the P-loop of the 
EIIB-like motif which is a conserved region that contains a phosphorylated cysteine in EIIB 
motifs of the PTS (138).  In the AtxA structural model, C402, and thus the P-loop, may 
contact residues in the adjoining AtxA molecule and phosphorylation of this loop may 
significantly impact multimerization.  Moreover, the pocket containing C402’, C161, and C202  
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Figure 6-3. Areas of interest in the structural model of the AtxA homodimer. 
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Figure 6-3. Areas of interest in the structural model of the AtxA homodimer. Three 
areas of the AtxA homodimer contain residues that have been shown to be important 
experimentally or in silico. A. The model of the homodimer is presented alongside a 90° 
rotation of the structure.  One monomer is colored blue and the other is grey. Side chains of 
the important residues are depicted as spheres.  The color scheme is the same for all 
panels.  B. The EIIB-like motifs from both chains are displayed. The C402 residues (yellow) 
are on opposite sides of the motifs.  Between the motifs, R415, F468, and K472 (red) may 
form a metal-binding pocket. C. The region surrounding C402 (yellow) from one monomer 
contains C161, H199, C202, and H379 (magenta) from the second subunit.   D.  Depicted is 
a potential interaction between N453 (orange) of the AtxA EIIB-like motif and the WH motif 
(green) from the structure of the Mga-like protein (PDB = 3SQN, chain A).  
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also harbors H199 and H379, the phosphorylation sites of AtxA (Fig. 6-3C).  If C402 is 
phosphorylated, it may present an ionic clash and steric hindrance with a phosphohistidine at 
H199 or H379.   
The AtxA structural model displays residues that may interact with phosphorylated 
H199 and H379.  According to the Domain Swing/Lock Mechanism, phosphohistidine at 
H199 should increase the stability of an AtxA dimer.  The phosphohistidines of LicT interact 
with arginine residues of the adjacent subunit (135).  H199 slightly extends into the adjacent 
EIIB-like motif suggesting that it forms important contacts.  AtxA H199-phosphate may 
interact with R424’ to increase the AtxA-AtxA affinity.  Likewise, H379 extends away from the 
core of PRD2 and toward the interface with the EIIB-like motif of the second AtxA subunit.  
The helix containing H379 also harbors several non-polar residues (L375, M378, T382, and 
M385) that face non-polar amino acids on the complementary alpha-helix of the EIIB-like 
motif (I403’, Y406’, and L411’). H379 in its non-phosphorylated form may interact with Y406’.  
When phosphorylated, H379 could disrupt the hydrophobicity of the region and destabilize 
the dimer.  The AtxA multimerization model predicts that H379 inhibits proper multimer 
formation. 
 In silico analysis of the AtxA structural model suggests that zinc and magnesium may 
bind to the protein.  The 3DLigandSite Server (185) suggests that R415, F468, and K472 of 
both AtxA subunits interact with the metal ions.  It is significant that these residues form an 
interface between the EIIB-like motifs of each subunit (Fig. 6-3B).  A metal ion may also bind 
the Mga protein of GAS.  McIver and co-authors have suggested that Mga chelates a metal 
as it is expressed in E. coli and S. pyogenes (McIver, personal communication).  Mutation of 
R415, F468, and K472 may have a substantial impact on homodimer formation and metal 
binding. 
Another interesting observation was made when constructing a model of a 
heterodimer of the Mga-like protein and AtxA.  In the model, N453 of AtxA resides next to a 
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loop between the WH and HTH motifs of the Mga-like protein (Fig. 6-3D).  The structure of 
the loop (Mga-like protein residues 76-78) was not detected in the Mga-like protein crystal 
structure which suggests that it is flexible.  As described above, Fouet and colleagues 
suggest that N453 binds to bicarbonate (Fouet, personal communication).  If N453 interacts 
with a bicarbonate ion, then the loop may become more rigid and alter the conformation of 
the adjacent WH and HTH motifs.  The change in WH and HTH orientation may allow AtxA to 
bind DNA efficiently and specifically.  Bicarbonate binding via N453 may be the final step in 
AtxA dimerization.  
The structural model of the AtxA homodimer has provided support for my 
experimental data.  As with all in silico analyses, this structural model provides rationale for 
many additional experiments. 
 
6.7 Concluding remarks 
Future studies of AtxA will answer several lingering questions.  Does AtxA bind to 
bicarbonate?  Which proteins phosphorylate AtxA?  Does AtxA form a dimer and is that 
dimer structurally similar to the Mga-like protein?  How does AtxA associate with DNA?   
Future data will support an emerging model in microbial pathogenesis which suggests 
that there is a relationship between host signals and virulence gene expression.  Many 
pathogenic bacteria effectively colonize environmental niches that are very different from the 
conditions within their susceptible host.  Borrelia burgdorferi inhabits a tick before infecting a 
mammal, Vibrio cholerae is a water-borne bacterium prior to taking up residence in the 
human intestines, and B. anthracis dwells in the soil before rapidly replicating within its host.  
Signal transduction pathways leading to virulence gene expression must differentiate 
between the cues in each location.  Interestingly, these signals affect basic bacterial 
physiology.  B. anthracis senses the temperature, carbohydrate availability, and 
CO2/bicarbonate concentration to regulate atxA and virulence gene expression.  My doctoral 
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studies have helped to understand the link between these fundamental processes and 
pathogenesis. 
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